10-Q

 UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

x   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2013

OR

o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to            

Commission File Number 0-51378

TECHPRECISION CORPORATION

(Exact name of registrant as specified in its charter)

DELAWARE	51-0539828
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
3477 Corporate  Parkway, Center Valley, PA	18034
(Address of principal executive offices)	(Zip Code)

(484) 693-1700

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    

Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    

Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	o	Accelerated filer	o
Non-Accelerated Filer	o	Smaller reporting company	x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  

Yes o No x

The number of shares of the Registrant’s common stock, par value $0.0001 per share, issued and outstanding at November 8, 2013 was 19,956,871.

TABLE OF CONTENTS

		Page
PART I.	FINANCIAL INFORMATION	3
ITEM 1.	FINANCIAL STATEMENTS	3
	CONDENSED CONSOLIDATED BALANCE SHEETS	3
	CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS	4
	CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS	5
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	17
ITEM 4.	CONTROLS AND PROCEDURES	24
PART II.	OTHER INFORMATION	25
ITEM 1A.	RISK FACTORS	25
ITEM 6.	EXHIBITS	25
	SIGNATURES	26
EXHIBIT INDEX

2

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

 TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

	September 30, 2013				March 31, 2013
ASSETS
Current assets:
Cash and cash equivalents		$	1,532,026			$	3,075,376
Accounts receivable, less allowance for doubtful accounts of $25,010 in 2013 and 2012			2,690,517				4,330,637
Costs incurred on uncompleted contracts, in excess of progress billings			5,064,036				4,298,293
Inventories- raw materials			355,168				354,516
Income taxes receivable			374,030				374,030
Current deferred taxes			255,765				255,765
Other current assets			1,388,393				1,578,484
Total current assets			11,659,935				14,267,101
Property, plant and equipment, net			6,907,282				7,300,248
Total assets		$	18,567,217			$	21,567,349
LIABILITIES AND STOCKHOLDERS’ EQUITY:
Current liabilities:
Accounts payable		$	1,247,729			$	2,537,060
Contract loss provision			1,697,975				270,172
Accrued expenses			803,961				1,604,752
Accrued taxes payable			232,624				232,624
Deferred revenues			677,907				253,813
Short-term debt			--				500,000
Current maturity of long-term debt			5,418,227				5,784,479
Total current liabilities			10,078,423				11,182,900
Long-term debt, including capital leases			43,532				31,108
Noncurrent deferred taxes			255,765				255,765
Commitments and contingent liabilities (see Note 16)
Stockholders’ Equity:
Preferred stock- par value $.0001 per share, 10,000,000 shares authorized,
of which 9,890,980 are designated as Series A Preferred Stock, with
5,532,998 shares issued and outstanding at September 30, 2013 and March 31, 2013,
(liquidation preference of $1,576,904 at September 30, 2013 and March 31, 2013)			1,310,206				1,310,206
Common stock -par value $.0001 per share, authorized, 90,000,000 shares
issued and outstanding, 19,956,871 shares at September 30, 2013 and March 31, 2013			1,996				1,996
Additional paid in capital			5,290,840				5,076,552
Accumulated other comprehensive loss			(101,210	)			(221,418	)
Retained earnings			1,687,665				3,930,240
Total stockholders’ equity			8,189,497				10,097,576
Total liabilities and stockholders’ equity		$	18,567,217			$	21,567,349

See accompanying notes to the condensed consolidated financial statements.

3

 TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Unaudited)

	Three Months Ended September 30						Six Months Ended  September 30
	2013			2012			2013			2012
Net sales	$	5,195,795		$	8,078,552		$	12,292,487		$	15,224,291
Cost of sales		4,468,523			6,140,187			11,144,972			12,180,487
Gross profit		727,272			1,938,365			1,147,515			3,043,804
Selling, general and administrative		1,484,487			1,924,079			3,254,569			3,924,599
(Loss) income from operations		(757,215	)		14,286			(2,107,054	)		(880,795	)
Other income, expense		6,985			2,558			(567	)		2,511
Interest expense		(67,646	)		(74,394	)		(137,773	)		(154,485	)
Interest income		(794	)		1,188			2,819			2,881
Total other expense, net		(61,455	)		(70,648	)		(135,521	)		(149,093	)
Loss before income taxes		(818,670	)		(56,362	)		(2,242,575	)		(1,029,888	)
Income tax benefit		--			(11,342	)		--			(278,599	)
Net loss	$	(818,670	)	$	(45,020	)	$	(2,242,575	)	$	(751,289	)
Other comprehensive (loss) income, before tax:
Change in unrealized loss on cash flow hedges		(7,476	)		(8,552	)		(117,813	)		(79,143	)
Foreign currency translation adjustments		(184	)		26,214			(2,396	)		14,111
Other comprehensive income (loss), before tax		(7,660	)		17,662			(120,209	)		(65,032	)
Net tax benefit of other comprehensive loss items		--			(3,374	)		--			(31,219	)
Other comprehensive (loss) income, net of tax		(7,660	)		21,036			(120,209	)		(33,813	)
Comprehensive loss	$	(826,330	)	$	(23,984	)	$	(2,362,784	)	$	(785,102	)
Net loss per share (basic)	$	(0.04	)	$	(0.00	)	$	(0.11	)	$	(0.04	)
Net loss per share (diluted)	$	(0.04	)	$	(0.00	)	$	(0.11	)	$	(0.04	)
Weighted average number of shares outstanding (basic)		19,956,871			18,696,846			19,956,871			18,614,112
Weighted average number of shares outstanding (diluted)		19,956,871			18,696,846			19,956,871			18,614,112

See accompanying notes to the condensed consolidated financial statements.

4

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Six Months Ended September 30,
	2013			2012
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(2,242,575	)	$	(751,289	)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization		478,902			415,429
Stock based compensation expense		214,287			282,719
Deferred income taxes		--			(282,020	)
Provision for contract losses		1,427,803			83,196
Changes in operating assets and liabilities:
Accounts receivable		1,644,073			219,289
Costs incurred on uncompleted contracts, in excess of progress billings		(765,743	)		(948,192	)
Inventories – raw materials		1,283			(202,361	)
Other current assets		180,499			61,199
Taxes receivable		--			553,070
Other noncurrent assets		--			88,126
Accounts payable		(1,295,237	)		664,632
Accrued expenses		(682,920	)		(1,036,974	)
Deferred revenues		423,547			931,453
Net cash (used in) provided by operating activities		(616,081	)		78,277
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment		(53,941	)		(75,109	)
Net cash used in investing activities		(53,941	)		(75,109	)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayment of debt		(875,278	)		(683,928	)
Net cash used in financing activities		(875,278	)		(683,928	)
Effect of exchange rate on cash and cash equivalents		1,950			(3,969	)
Net decrease in cash and cash equivalents		(1,543,350	)		(684,729	)
Cash and cash equivalents, beginning of period		3,075,376			2,823,485
Cash and cash equivalents, end of period	$	1,532,026		$	2,138,756

See accompanying notes to the condensed consolidated financial statements.

5

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(Continued)

	Six Months Ended September 30,
	2013		2012
SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION
Cash paid during the period for:
Interest	$	127,306	$	140,138
Income taxes	$	--	$	--

SUPPLEMENTAL INFORMATION – NONCASH INVESTING AND FINANCING TRANSACTIONS:

Six Months Ended September 30, 2013

For the six months ended September 30, 2013, we recorded a liability of $271,168 (net of tax of $0) to reflect the fair value of an interest rate swap contract in connection with a tax exempt bond financing transaction.

Six Months Ended September 30, 2012

For the six months ended September 30, 2012, we issued 912,400 shares of common stock in connection with the conversion of 697,984 shares of Series A Convertible Preferred Stock.

For the six months ended September 30, 2012, Ranor entered into a capital lease arrangement for $46,378 for new office equipment.

We recorded a liability of $275,315 (net of tax of $179,339) to reflect the fair value of an interest rate swap contract in connection with a tax exempt bond financing transaction.

See accompanying notes to the condensed consolidated financial statements.

6

TECHPRECISION CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1 - DESCRIPTION OF BUSINESS

TechPrecision Corporation offers a full range of services required to transform metallic raw materials into precise finished products We manufacture large scale metal fabricated and machined precision components and equipment. These products are used in a variety of markets including the alternative energy, medical, nuclear, defense, commercial, and aerospace industries. We sell to customers in three main industry groups: naval/maritime, energy and precision industrial.

We are a Delaware corporation organized in February 2005 under the name Lounsberry Holdings II, Inc. The name was changed to TechPrecision Corporation on March 6, 2006. TechPrecision is the parent company of Ranor, Inc., or Ranor, a Delaware corporation. On November 4, 2010, TechPrecision announced it completed the formation of a wholly foreign owned enterprise (WFOE), under the laws of the People’s Republic of China, Wuxi Critical Mechanical Components Co., Ltd., or WCMC, to meet growing demand for local manufacturing of components in China. TechPrecision, WCMC and Ranor are collectively referred to as the “Company,” “we,” “us” or “our.”

Liquidity and Capital Resources

At September 30, 2013, we were in default and continue to be in default with the Loan and Security Agreement between Ranor and Sovereign Bank, or the Bank, dated February 24, 2006, as amended, or the Loan Agreement. At March 31, 2013, we were not in compliance with the fixed charges and interest coverage financial covenants under the Loan Agreement, and the Bank did not agree to waive our non-compliance with the covenants. As a result, we were in default at March 31, 2013. In addition, the Bank did not renew the revolving credit facility which expired on July 31, 2013. The Bank has the right to accelerate payment of the debt in full upon 60 days written notice. As a consequence, all amounts under the Loan Agreement are classified as a current liability at September 30, 2013 ($5.4 million) and March 31, 2013 ($5.8 million). The Bank continues to evaluate its course of action and has not yet demanded repayment. We continue to make payments pursuant to the terms of the Loan Agreement. If the Bank were to make such a demand for repayment, we would be unable to pay the obligation as we do not have existing facilities or sufficient cash on hand to satisfy these obligations and would need to seek alternative financing. The covenants under the loan agreement are no longer being tested on a monthly, quarterly or annual basis.

We have incurred net losses of $2.2 million for the first six months of the year ending March 31, 2014, or fiscal 2014, and $2.4 million and $2.1 million for the annual periods ended March 31, 2013 and 2012, respectively. At September 30, 2013 we had cash and cash equivalents of $1.5 million of which $0.1 million is located in China and which we may not be able to repatriate for use in the U.S. without undue cost or expense if at all. We borrowed $0.5 million under our revolving line of credit during the quarter ended March 31, 2013, and repaid this borrowing in full in July 2013. In addition, we have $0.9 million of restricted cash with the Bank (included in our other current assets) that could be used toward satisfying our obligation under the Loan Agreement.

These factors raise substantial doubt about our ability to continue as a going concern. In order for us to continue operations beyond the next twelve months and be able to discharge our liabilities and commitments in the normal course of business, we must secure long-term financing on terms consistent with our business plans. In addition, we must increase our backlog and change the composition of our revenues to focus on recurring unit of delivery projects rather than custom first article and prototyping projects which do not efficiently use our manufacturing capacity, and reduce our operating expenses to be in line with current business conditions in order to increase profit margins and decrease the amount of cash used in operations. If we are successful in changing the composition of revenue and reducing costs, we expect that fiscal 2014 operating results will reflect positive operating cash flows. However, we plan to closely monitor our expenses and, if required, will further reduce operating costs and capital spending to enhance liquidity.

The condensed consolidated financial statements for the three and six months ended September 30, 2013 and the year ended March 31, 2013, or fiscal 2013, were prepared on the basis of a going concern which contemplates that we will be able to realize assets and discharge liabilities in the normal course of business. Accordingly, they do not give effect to adjustments that would be necessary should we be required to liquidate assets. Our ability to satisfy our total current liabilities of $10.1 million at September 30, 2013 and to continue as a going concern is dependent upon the availability of and our ability to timely secure long-term financing and the successful execution of our operating plan. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.

7

NOTE 2 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying condensed consolidated financial statements include the accounts of TechPrecision, WCMC and Ranor. Intercompany transactions and balances have been eliminated in consolidation. The accompanying condensed consolidated balance sheet as of September 30, 2013, the condensed consolidated statements of operations and comprehensive loss for the three and six months periods ended September 30, 2013 and 2012, and the condensed consolidated statements of cash flows for the six months ended September 30, 2013 and 2012 are unaudited, but in the opinion of management, include all adjustments that are necessary for a fair presentation of our financial statements for interim periods in accordance with U.S. Generally Accepted Accounting Principles, or U.S. GAAP. All adjustments are of a normal, recurring nature, except as otherwise disclosed. The results of operations for an interim period are not necessarily indicative of the results of operations to be expected for the fiscal year.

The Notes to Condensed Consolidated Financial Statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission, or SEC, for Quarterly Reports on Form 10-Q. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. These unaudited financial statements and related notes should be read in conjunction with our consolidated financial statements included with our Annual Report on Form 10-K, or 2013 Form 10-K, filed with the SEC for the year ended March 31, 2013.

Significant Accounting Policies

Our significant accounting policies are set forth in detail in Note 2 to the 2013 Form 10-K.

NOTE 3 – RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS

In July 2013, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update (ASU) No. 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (a consensus of the FASB Emerging Issues Task Force), orASU 2013-11, which provides clarification on the financial statement presentation of unrecognized tax benefits. ASU 2013-11 specifies that an unrecognized tax benefit (or a portion thereof) shall be presented in the financial statements as a reduction to a deferred tax asset when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. If such deferred tax asset is not available at the reporting date to settle additional income taxes resulting from the disallowance of a tax position, or the entity does not plan to use the deferred tax asset for such purpose given the option, the unrecognized tax benefit shall be presented in the financial statements as a liability and shall not be combined with deferred tax assets. The amendments in ASU 2013-11 are effective for fiscal years (and interim periods within those years) beginning after December 15, 2013, with early adoption permitted. We are currently evaluating the impact of adopting ASU 2013-11, but do not believe the new guidance will have a material impact on the balance sheet presentation of its unrecognized tax benefits based on the nature of these items.

In July 2013, the FASB issued No. ASU 2013-10, Derivatives and Hedging – Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purpose, or ASU 2013-10, permitting entities to designate the Fed Funds Effective Swap Rate as a U.S. benchmark interest rate for hedge accounting purposes. Prior to the issuance of this guidance, only interest rates on direct treasury obligations of the U.S. government and the LIBOR swap rate were considered benchmark interest rates in the U.S. This guidance is effective immediately and can be applied prospectively for qualifying new or re-designated hedging relationships entered into on or after July 17, 2013. We do not use the Fed Funds Effective Swap Rate as a benchmark interest rate.

In March 2013, the FASB issued ASU No. 2013-05, Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity, or ASU 2013-05, which provides guidance for the treatment of the cumulative translation adjustment when an entity ceases to hold a controlling financial interest in a subsidiary or group of assets within a foreign entity. ASU 2013-05 is effective for interim and annual reporting periods beginning after December 15, 2013. We are currently evaluating the impact of adopting ASU 2013-05 on our results of operations, financial position or cash flows.

In February 2013, the FASB issued ASU No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, or ASU 2013-02, which requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under U.S. GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under U.S. GAAP that provide additional detail about those amounts. The new guidance is effective prospectively for fiscal years (and interim periods within those years) beginning after December 15, 2013, with early adoption permitted. The Company does not believe that the new guidance will have a material impact on our financial position and results of operations.

8

NOTE 4 - PROPERTY, PLANT AND EQUIPMENT

	September 30, 2013			March 31, 2013
Land	$	110,113		$	110,113
Building and improvements		3,261,680			3,261,680
Machinery equipment, furniture and fixtures		8,882,938			8,826,050
Equipment under capital leases		65,568			46,378
Total property, plant and equipment		12,320,299			12,244,221
Less: accumulated depreciation		(5,413,017	)		(4,943,973	)
Total property, plant and equipment, net	$	6,907,282		$	7,300,248

Depreciation expense for the three and six months ended September 30, 2013 and 2012 was $220,604 and $469,044, and $195,727 and $388,650, respectively.

NOTE 5 - COSTS INCURRED ON UNCOMPLETED CONTRACTS

	September 30, 2013			March 31, 2013
Cost incurred on uncompleted contracts, beginning balance	$	6,180,839		$	10,879,743
Total cost incurred on contracts during the period		11,190,624			21,215,441
Less cost of sales, during the period		(11,144,972	)		(25,914,345	)
Cost incurred on uncompleted contracts, ending balance	$	6,226,491		$	6,180,839
Billings on uncompleted contracts, beginning balance	$	1,882,546		$	6,969,717
Plus: Total billings incurred on contracts, during the period		11,572,396			27,385,748
Less: Contracts recognized as revenue, during the period		(12,292,487	)		(32,472,919	)
Billings on uncompleted contracts, ending balance	$	1,162,455		$	1,882,546
Cost incurred on uncompleted contracts, ending balance	$	6,226,491		$	6,180,839
Billings on uncompleted contracts, ending balance		1,162,455			1,882,546
Costs incurred on uncompleted contracts, in excess of progress billings	$	5,064,036		$	4,298,293

Contract costs consist primarily of labor and materials and related overhead, to the extent that such costs are recoverable. Revenues associated with these contracts are recorded only when the amount of recovery can be estimated reliably and realization is probable.

As of September 30, 2013 and March 31, 2013, we had deferred revenues totaling $677,907 and $253,813, respectively. Deferred revenues represent customer prepayments on their contracts and completed contracts on which all revenue recognition criteria were not met. We record provisions for losses within costs of sales in our condensed consolidated statement of operations and comprehensive loss. We also receive advance billings and deposits representing down payments for acquisition of materials and progress payments on contracts. The agreements with our customers allow us to offset the progress payments against the costs incurred.

We continued to incur losses on a certain customer projects at September 30, 2013. These losses are included in our statement of operations for the six months ended September 30, 2013. We have recorded $1.4 million of contract losses in our financial statements for the six months ended September 30, 2013. We are in dialogue with customers to remedy project design and production activities that have caused these losses. When product design and production require alteration we endeavor to secure change orders from our customers.

9

NOTE 6 – OTHER CURRENT ASSETS

	September 30, 2013		March 31, 2013
Payments advanced to suppliers	$	229,449	$	267,513
Prepaid insurance		151,316		187,086
Collateral deposits (see Note 8)		927,462		1,032,348
Deferred loan costs, net of amortization		42,201		57,930
Other		37,965		33,607
Total	$	1,388,393	$	1,578,484

NOTE 7 – ACCRUED EXPENSES

	September 30, 2013		March 31, 2013
Accrued compensation	$	413,901	$	668,038
Interest rate swaps market value		271,168		388,982
Customer deposits		--		236,000
Other		118,892		311,732
Total	$	803,961	$	1,604,752

NOTE 8 – DEBT

Debt obligations outstanding were classified as of:	September 30, 2013		March 31, 2013
Sovereign Bank Capital Expenditure Note due November 2014	$	229,824	$	306,432
Sovereign Bank Staged Advance Note due March 2016		287,482		333,850
MDFA Series A Bonds due January 2021		3,683,333		3,789,583
MDFA Series B Bonds due January 2018		1,207,143		1,346,429
Obligations under capital leases		10,445		8,185
Total short-term debt	$	5,418,227	$	5,784,479
Long-term obligations under capital leases		43,532		31,108
Total debt	$	5,461,759	$	5,815,587

On February 24, 2006, we entered into the Loan Agreement, with the Bank which has since been amended as further described below. Pursuant to the Loan Agreement, as amended, the Bank provided us with a secured term loan of $4.0 million, or the Term Note, and a revolving line of credit of up to $2.0 million, or Revolving Note. On January 29, 2007, the Loan Agreement was amended, adding a capital expenditure line of credit facility of $3.0 million, or Capital Expenditure Note. On March 29, 2010, the Bank agreed to extend to us a loan facility, or Staged Advance Note, in the amount of up to $1.9 million for the purpose of acquiring a gantry mill machine.

On December 30, 2010, we completed a $6.2 million tax exempt bond financing with the Massachusetts Development Finance Authority, or the MDFA, pursuant to which the MDFA sold to the Bank MDFA Revenue Bonds, Ranor Issue, Series 2010A in the original aggregate principal amount of $4.25 million, or Series A Bonds, and MDFA Revenue Bonds, Ranor Issue, Series 2010B in the original aggregate principal amount of $1.95 million, or Series B Bonds. We refer to Series A Bonds and Series B Bonds together as the Bonds. The proceeds of such sales were loaned to us under the terms of a Mortgage Loan and Security Agreement, dated as of December 1, 2010, by and among us, MDFA and the Bank (as Bond owner and disbursing Agent), or the MLSA.

In connection with the December 30, 2010 bond financing, we executed an Eighth Amendment to the Loan Agreement, or Eighth Amendment. The Eighth Amendment incorporated borrowing of the Bond proceeds into the borrowings covered by the Loan Agreement. The MLSA provides for customary events of default, including any event of default under the Loan Agreement described above. Subject to lapse of any applicable cure period, a default under the MLSA would cause the acceleration of all of our outstanding obligations under the MLSA. Under the MLSA and the Eighth Amendment, we were required, as of the end of each fiscal quarter, to meet certain financial covenants applicable while the Bonds remain outstanding, including, among other things, that the ratio of earnings available to cover fixed charges will be greater than or equal to 120%; the interest coverage ratio will equal or exceed 2:1; and that our leverage ratio will be less than or equal to 3:1.

On August 8, 2011, an appraisal was completed on our Westminster, Massachusetts property assigning a value of $4.8 million to such property. The Series A Bonds require that the loan-to-value ratio not exceed 75%, indicating a maximum loan amount of $3.6 million.

The bond balance exceeded such maximum loan amount at September 30, 2011 by approximately $490,000. On October 28, 2011, we and the Bank agreed to resolve the collateral shortfall by establishing a separate interest bearing restricted cash account in the amount of $490,000 which is pledged as additional collateral to the debt and restricted from use for any other purpose. The required restricted balance is being amortized down at the current monthly debt principal amount of $17,708. At September 30, 2013, the restricted cash is classified as a collateral deposit in other current assets of $83,219.

At December 31, 2011, we were in compliance with our leverage ratio bank covenant. However, we did not meet the ratio of earnings available to cover fixed charges or the interest coverage ratio covenants. In February 2012, we executed a Tenth Amendment and obtained a waiver of the breach of such covenants from the Bank, which waiver covered the breach that otherwise would have occurred in connection with the covenant testing for the third quarter ended December 31, 2011 and waived the ratio of earnings available to cover fixed charges covenant at March 31, 2012. This waiver did not apply to any future covenant testing dates.

10

On July 6, 2012, we executed an Eleventh Amendment and obtained a waiver for failure to comply with the fixed charge coverage ratio and the interest coverage ratio covenants at March 31, 2012. The Eleventh Amendment also waived the covenant testing requirements related to the ratio of earnings available to cover fixed charges and the interest coverage ratio for the fiscal quarters ended June 30, 2012 and September 30, 2012. The leverage ratio covenant remained in effect, and must not be greater than 2:1. We were in compliance with the leverage ratio covenant at September 30, 2012, as the actual leverage ratio was 1:1. Although there was no testing of the covenant to comply with the ratio of earnings available to cover fixed charges and the interest coverage covenants for the fiscal quarters ended June 30 and September 30, 2012, the Bank required that we have earnings before interest and taxes (EBIT) greater than $1 for the fiscal quarter ended September 30, 2012. We reported EBIT of $14,286 for the fiscal quarter ended September 30, 2012 and, therefore, were in compliance with this covenant. The $1 EBIT covenant at September 30, 2012 is not applicable to any future periods as testing of all covenants resumed on December 31, 2012 according to the terms of the Eleventh Amendment.

Under the Eleventh Amendment the covenants were revised such that we were not to permit earnings available for fixed charges to be less than 125%, the interest coverage ratio to be less than 2:1, and the leverage ratio to be greater than 2:1 at any time, tested quarterly. Also, in connection with the Eleventh Amendment, we paid the Bank a fee of $10,000 and made a collateral deposit of $840,000 to cover estimated principal and interest on our obligation. This collateral was to be released to us upon successful compliance with all debt covenant tests. The Eleventh Amendment also revised covenant testing to provide that the ratio of earnings available to cover fixed charges and the interest coverage ratio covenant testing was to resume at December 31, 2012 on a trailing six month basis, and continue at March 31, 2013 on a trailing nine month basis and quarterly thereafter on a trailing twelve month basis beginning on June 30, 2013.

On February 14, 2013, we executed a Twelfth Amendment and obtained a waiver for failure to comply with the fixed charge coverage ratio and the interest coverage ratio covenants at December 31, 2012. The actual fixed charge ratio at December 31, 2012 was negative 41% and the actual interest coverage ratio was negative 256% as we reported an operating loss for the three months ended December 31, 2012. The leverage ratio covenant remained in effect (and must not be greater than 2:1). We were in compliance with the leverage ratio covenant at December 31, 2012, as the actual leverage ratio was 1:1. The Twelfth Amendment revised the covenant to provide that the ratio of earnings available to cover fixed charges and the interest ratio coverage covenant testing resumed at March 31, 2013 on a trailing three month basis, and continued at June 30, 2013 on a trailing six month basis, at September 30, 2013 on a trailing nine month basis, and quarterly thereafter on a trailing twelve month basis beginning at December 31, 2013. Also, in connection with the Twelfth Amendment, we paid the Bank a fee of $7,500 and were required to continue to maintain a collateral deposit of $840,000 to cover estimated principal and interest on our obligation. A collateral deposit of $844,243 is included in other current assets at September 30, 2013.

At September 30, 2013, we were in default and continue to be in default with the Loan Agreement with the Bank. At March 31, 2013, we were not in compliance with the fixed charges and interest coverage financial covenants under the Loan Agreement, and the Bank did not agree to waive the non-compliance with the covenants. As a result, we were in default at March 31, 2013. In addition, the Bank did not renew the revolving credit facility which expired on July 31, 2013. The Bank has the right to accelerate payment of the debt in full upon 60 days written notice. As a consequence, all amounts under the Loan Agreement are classified as a current liability at September 30, 2013 ($5.4 million) and March 31, 2013 ($5.8 million). The Bank continues to evaluate its course of action and has not yet demanded repayment. We continue to make payments pursuant to the terms of the Loan Agreement. If the Bank were to make such a demand for repayment, we would be unable to pay the obligation as we do not have existing facilities or sufficient cash on hand to satisfy these obligations and would need to seek alternative financing.

At March 31, 2013 the actual fixed charge ratio was negative 81% and the actual interest coverage ratio was negative 351% as we reported an operating loss for the three months ended March 31, 2013. The leverage ratio covenant remained in effect (and must not be greater than 2:1). We were in compliance with the leverage ratio covenant at March 31, 2013, as the actual leverage ratio was 1:1. The covenants under the loan agreement are no longer being tested on a monthly, quarterly or annual basis.

Term Note:

The Term Note issued on February 24, 2006 has a term of 7 years with an initial fixed interest rate of 9%. The interest rate on the Term Note converted from a fixed rate of 9% to a variable rate on February 28, 2011. From February 28, 2011 until maturity the Term Note will bear interest at the Prime Rate plus 1.5% (4.75% at March 31, 2013), payable on a quarterly basis. Principal was paid in quarterly installments of $142,857, plus interest, with a final payment made on March 1, 2013. There was $0 and $0 outstanding under this facility at September 30, 2013 and March 31, 2013, respectively.

11

MDFA Series A and B Bonds:

On December 30, 2010, we and Ranor completed a $6.2 million tax exempt bond financing with the MDFA pursuant to which the MDFA sold the Bonds to the Bank and loaned the proceeds of such sale to Ranor under the terms of the MLSA.

The proceeds from the sale of the Series A Bonds were used to finance the Ranor facility acquisition and 19,500 sq. ft. expansion of Ranor’s manufacturing facility located in Westminster, Massachusetts, and the proceeds from the sale of the Series B Bonds were used to finance acquisitions of qualifying manufacturing equipment installed at the Westminster facility. Under the MLSA and related documents, the Westminster facility secures, and we further guarantee, Ranor’s obligations to the Bank and subsequent holders of the Bonds.

The initial rate of interest on the Bonds was 1.96% for a period from the bond date to and including January 31, 2011, and the interest rate thereafter is 65% times the sum of 275 basis points plus one-month LIBOR. The interest rate at September 30, 2013 was 3.725%. We are required to make monthly payments of $17,708 and $23,214 with respect to the Loans beginning on February 1, 2011 until the maturity date or earlier redemption of each Bond. The Series A Bonds and the Series B Bonds will mature on January 1, 2021 and January 1, 2018, respectively. The Bonds are redeemable pursuant to the MLSA prior to maturity, in whole or in part, on any payment date in accordance with the terms of the MLSA.

In connection with the Bond financing, we and the Bank entered into the International Swap and Derivatives Association, Inc. 2002 Master Agreement, dated December 30, 2010, or ISDA Master Agreement, pursuant to which the variable interest rates applicable to the Bonds were swapped for fixed interest rates of 4.14% on the Series A Bonds and 3.63% on the Series B Bonds. Under the ISDA Master Agreement, we and the Bank entered into two swap transactions, each with an effective date of January 3, 2011. The notional amount of outstanding fair value interest rate swaps totaled $4.9 and $5.6 million at September 30, 2013 and March 31, 2013, respectively. These derivative instruments, which are designated as cash flow hedges, are carried on our consolidated balance sheet at fair value with the effective portion of the gain or loss on the derivative reported in stockholders’ equity as a component of accumulated other comprehensive loss and subsequently reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. The swaps will terminate on January 4, 2021 and January 2, 2018, respectively. The fair value of the interest rate swaps contracts were measured using market based level 2 inputs. The method employed to calculate the values conforms to the industry convention. The swap’s market value can be calculated any time by comparing the fixed rate set at the inception of the transaction and the “swap replacement rate,” which represents the market rate for an offsetting interest rate swap with the same Notional Amounts and final maturity date. The market value is then determined by calculating the present value interest differential between the contractual swap and the replacement swap. The termination value is the sum of the present value interest differential as described above plus the accrued interest due at termination.

Revolving Note:

We and the Bank agreed to extend the maturity date of the revolving credit facility to July 29, 2012 under the Ninth Amendment to the Loan Agreement. The maturity date of the revolving credit facility was extended to January 31, 2013 under the Eleventh Amendment, and was extended further to July 31, 2013 under the Twelfth Amendment. The Revolving Note bears interest at a variable rate determined as the Prime Rate, plus 1.5% annually on any outstanding balance. The borrowing limit on the Revolving Note is limited to the sum of 70% of our eligible accounts receivable plus 40% of eligible inventory up to a maximum borrowing limit of $2.0 million. In July 2013, we repaid the $500,000 borrowed under the Revolving Note. This facility expired by its terms on July 31, 2013 and was not renewed by the Bank. As of March 31, 2013 there was $500,000 borrowed and outstanding under this facility and $1.5 million was available under this facility.

Capital Expenditure Note:

The initial borrowing limit under the Capital Expenditure Note was $0.5 million and has been amended several times resulting in a borrowing limit of $3.0 million. On November 30, 2009, we elected not to renew this facility when it terminated. Borrowings outstanding under this facility were converted to a note when the facility terminated. The current rate of interest is LIBOR plus 3% or 3.18% at September 30, 2013. Principal and interest payments are due monthly based on a five year amortization schedule. The Capital Expenditure Note matures on November 30, 2014.

Staged Advance Note:

The Bank made certain loans to us limited to a cap of $1.9 million for the purpose of acquiring a gantry mill machine. The machine serves as collateral for the loan. The total aggregate amount of advances under this agreement could not exceed 80% of the actual purchase price of the gantry mill machine. All advances provided for a payment of interest only monthly through February 28, 2011, and thereafter, no further borrowings were permitted under this facility. The current interest rate is LIBOR plus 4% or 4.18% at September 30, 2013. Beginning on April 1, 2011, we were obligated to pay principal and interest sufficient to amortize the outstanding balance on a five year schedule. The Staged Advance Note matures on March 1, 2016.

12

Capital Lease:

We entered into a new capital lease in April 2012 in the amount of $46,378 for certain office equipment. The original lease term is for 63 months, bears interest at 6.0% and requires monthly payments of principal and interest of $860. This lease was amended in fiscal 2014 when we purchased another replacement copier at Ranor. The revised lease term was extended by nine months and will expire in March 2018. The amount of the lease recorded in property, plant and equipment, net was $53,977 and $37,544 as of September 30, 2013 and March 31, 2013, respectively.

NOTE 9 - INCOME TAXES

At the end of each interim period, we make an estimate of our annual U.S. and China expected effective tax rates. For the three and six months ended September 30, 2013, we recorded income tax expense of $0 and $0, respectively, and for the three and six months ended September 30, 2012, we recorded an income tax benefit of $11,342 and $278,599, respectively. The lack of a tax benefit for the three and six months ended September 30, 2013 was primarily the result of recording a full valuation allowance on our net deferred tax assets. A valuation allowance must be established for deferred tax assets when it is more likely than not that they will not be realized. The assessment was based on the weight of negative evidence at the balance sheet date, our recent operating losses and unsettled circumstances that, if unfavorably resolved, would adversely affect future operations and profit levels. We have determined that it is more likely than not that certain future tax benefits may not be realized.  A change in the estimates used to make this determination could require an increase in deferred tax assets if they become realizable.

As of September 30, 2013, our federal net operating loss carry-forward was approximately $2.3 million. If not utilized, the federal net operating loss carry-forward will begin to expire in 2025. Section 382 of the Internal Revenue Code provides for a limitation on the annual use of net operating loss carryforwards following certain ownership changes that could limit our ability to utilize these carryforwards on a yearly basis. We experienced an ownership change in connection with the acquisition of Ranor in 2006.

We file income tax returns in the U.S. federal jurisdiction, and various state jurisdictions. Our foreign subsidiary files separate income tax returns in the foreign jurisdiction in which it is located.  Tax years 2010 and forward remain open for examination.  We recognize interest and penalties accrued related to income tax liabilities in selling, general and administrative expense in our Condensed Consolidated Statements of Operations.

NOTE 10 - RELATED PARTY TRANSACTIONS

WCMC leased approximately 1,000 sq. ft. of office space from an affiliate of Cleantech Solutions International, or CSI, to serve as its primary office location in Wuxi, China. This lease expired on August 31, 2013. We are currently leasing the same space on a month to month basis. The original lease had an initial two-year term and rent under the lease with the CSI affiliate was approximately $17,000 on an annual basis. In addition to leasing property from an affiliate of CSI, we subcontract fabrication and machining services from CSI through their manufacturing facility in Wuxi, China and such subcontracted services are overseen by our personnel co-located at CSI in Wuxi, China. During the lease period, we viewed CSI as a related party because a holder of an approximate 5% fully diluted equity interest in CSI also held an approximate 36% fully diluted equity interest in TechPrecision. We paid $0.0 and $0.5 million to CSI for materials and manufacturing services for the six months ended September 30, 2013 and 2012, respectively. WCMC is also subcontracting manufacturing services from other non-related party Chinese manufacturing companies on comparable terms as those it had with CSI. 

NOTE 11 - PROFIT SHARING PLAN

Ranor has a 401(k) profit sharing plan that covers substantially all Ranor employees who have completed 90 days of service. Ranor retains the option to match employee contributions. Our contributions were $3,093 and $6,725, for the three and six months ended September 30, 2013, respectively, and $5,543 and $10,703, for the three and six months ended September 30, 2012, respectively.

NOTE 12 - CAPITAL STOCK

Preferred Stock

We have 10,000,000 authorized shares of preferred stock and the Board of Directors has broad power to create one or more series of preferred stock and to designate the rights, preferences, privileges and limitation of the holders of such series. The Board of Directors has created one series of preferred stock - the Series A Convertible Preferred Stock.

Each share of Series A Convertible Preferred Stock was initially convertible into one share of common stock. As a result of our failure  to meet certain levels of earnings before interest, taxes, depreciation and amortization for the years ended March 31, 2006 and 2007, the conversion rate changed, and, at December 31, 2009, each share of Series A Convertible Preferred Stock was convertible into 1.3072 shares of common stock, with an effective conversion price of $0.218.  Based on the current conversion ratio, there were 7,232,735 common shares underlying the Series A Convertible Preferred Stock as of September 30, 2013 and March 31, 2013.

13

Upon any liquidation we would be required to pay $0.285 for each share of Series A Convertible Preferred Stock. The payment will be made before any payment to holders of any junior securities and after payment to holders of securities that are senior to the Series A Convertible Preferred Stock.

During fiscal 2013, 1,502,984 shares of Series A Convertible Preferred Stock were converted into 1,964,694 shares of common stock. We had 5,532,998 shares of Series A Convertible Preferred Stock outstanding at September 30, 2013 and March 31, 2013.

Common Stock Purchase Warrants

On February 15, 2011, we entered into a contract with a third party pursuant to which we issued two-year warrants to purchase 100,000 shares of common stock at an exercise price of $1.65 per share. Using the Black-Scholes options pricing formula assuming a risk free rate of 0.30%, volatility of 79%, an expected term of one year, and the price of the common stock on February 15, 2011 of $1.65 per share, the value of the warrant was calculated at $51,428, or $0.51 per share issuable upon exercise of the warrant. Since the warrant permitted delivery of unregistered shares, we have control in settling the contract by issuing equity. The cost of warrants was charged to selling, general and administrative. The warrants expired on February 14, 2013 and at March 31, 2013 there were no warrants outstanding.

Common Stock

We had 90,000,000 authorized common shares at September 30, 2013 and March 31, 2013, and there were 19,956,871 shares of common stock outstanding at September 30, 2013 and March 31, 2013.

NOTE 13 - STOCK BASED COMPENSATION

In 2006, the directors adopted, and the stockholders approved, the 2006 TechPrecision Corporation Long-term Incentive Plan, or, as amended, the Plan. The Plan provides for the grant of incentive and non-qualified options, stock grants, stock appreciation rights and other equity-based incentives to employees, including officers, and consultants. The Plan is to be administered by a committee of not less than two directors each of whom is to be an independent director. In the absence of a committee, the Plan is administered by the Board of Directors. Independent directors are not eligible for discretionary options. The maximum number of shares of common stock that may be issued under the Plan is 3,300,000 shares.

Pursuant to the Plan, each newly elected independent director receives at the time of his or her election, a five-year option to purchase 50,000 shares of common stock at the market price on the date of his or her election.  In addition, the Plan provides for the annual grant of an option to purchase 10,000 shares of common stock on July 1st of each year following the third anniversary of the date of his or her first election.  

On June 13, 2013 and pursuant to the Plan, we granted stock options to our Executive Chairman to purchase 100,000 shares of common stock at an exercise price of $0.67 per share, the fair market value on the date of grant. The options have a term of ten years and will vest in three equal installments on each of the grant date and first two anniversaries of the grant date subject to continuous service as a member of the board through the second anniversary of the grant date.

On June 13, 2013 and pursuant to the Plan, we granted stock options to certain executives to purchase 300,000 shares of common stock at an exercise price of $0.67 per share, the fair market value on the date of grant. The options have a term of ten years and will vest in three equal annual installments starting on the first anniversary of the grant date subject to continuous employment service.

The fair value was estimated using the Black-Scholes option-pricing model based on the closing stock prices at the grant date and the weighted average assumptions specific to the underlying options. Expected volatility assumptions are based on the historical volatility of our common stock. The risk-free interest rate was selected based upon yields of five-year U.S. Treasury issues. We use the simplified method for all grants to estimate the expected term of the option. We assume that stock options will be exercised evenly over the period from vesting until the awards expire. As such, the assumed period for each vesting tranche is computed separately and then averaged together to determine the expected term for the award. Because of our limited stock exercise activity we did not rely on our historical exercise data. The assumptions utilized for option grants during the six months ended September 30, 2013 were 100.7% for volatility, a risk free interest rate of 1.1%, and expected term of approximately six years. At September 30, 2013, 1,268,506 shares of common stock were available for grant under the Plan. The following table summarizes information about options for the most recent annual income statements presented: 

14

	Number Of			Weighted Average		Aggregate Intrinsic		Weighted Average Remaining Contractual Life
	Options			Exercise Price		Value		(in years)
Outstanding at 3/31/2013		2,484,000		$	1.027	$	776,475	9.07
Granted		400,000		$	0.670		--	--
Forfeited		(1,331,000	)	$	0.952		--	--
Outstanding at 9/30/2013		1,553,000		$	0.970	$	17,750	7.17
Vested or expected to vest 9/30/2013		1,553,000		$	0.970	$	17,750		7.17
Exercisable at 9/30/2013		1,001,667		$	0.986	$	17,750		5.22

At September 30, 2013, there was $350,652 of total unrecognized compensation cost related to stock options. These costs are expected to be recognized over the next four years. The total fair value of shares vested during the six months ended September 30, 2013 was $174,905.

The following table summarizes the activity of our stock options outstanding but not vested for the six months ended September 30, 2013:  

	Number of  Options		Weighted Average
Outstanding at 3/31/2013		854,334	$	1.249
Granted		400,000	$	0.670
Vested		(155,334)	$	1.126
Forfeited		(547,667)	$	1.171
Outstanding at 9/30/2013		551,333	$	0.941

We made a discretionary grant outside of the Plan on June 13, 2013 of 200,000 options at an exercise price of $0.67 per share, the fair market value on the date of grant, to our non-employee directors in recognition of their additional services while we seek a permanent chief executive officer. The options have a term of ten years and will vest in three equal installment amounts on each of the grant date and first anniversaries of the grants and are subject to continuous service as members of the board through the second anniversary of the grant date. Although the grants were made outside of the Plan, the terms of the options are the same as those issued under the Plan.

NOTE 14 - CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS

We maintain bank account balances, which, at times, may exceed insured limits. We have not experienced any losses with these accounts and believe that we are not exposed to any significant credit risk on cash. At September 30, 2013, there were accounts receivable balances outstanding from three customers comprising 68% of the total receivables balance.  

The following table sets forth information as to accounts receivable from customers who accounted for more than 10% of our accounts receivable balance as of: 

		September 30, 2013					March 31, 2013
Customer		Dollars		Percent			Dollars		Percent
	A	$	1,094,006		41	%	$	915,632		21	%
	B	$	392,321		15	%	$	235,714		5	%
	C	$	333,674		12	%	$	198,251		4	%
	D	$	200,875		8	%	$	2,379,078		55	%
	E	$	--		--	%	$	516,174		12	%

We have been dependent in each year on a small number of customers who generate a significant portion of our business, and these customers change from year to year. The following table sets forth information as to net sales from customers who accounted for more than 10% of our revenue for the six months ended:

		September 30, 2013					September 30, 2012
Customer		Dollars		Percent			Dollars		Percent
	A	$	2,991,169		24	%	$	1,631,652		11	%
	B	$	2,948,045		24	%	$	2,335,696		15	%
	C	$	1,300,063		10	%	$	478,360		3	%
	D	$	608,328		5	%	$	2,898,858		19	%
	E	$	774,184		6	%	$	3,361,526		22	%

15

NOTE 15 – SEGMENT INFORMATION

We consider our business to consist of one segment - metal fabrication and precision machining. A significant amount of our operations, assets and customers are located in the United States. The following table presents our geographic information (net sales and net property, plant and equipment) by the country in which the legal subsidiary is domiciled and assets are located:

	Net Sales				Property, Plant and Equipment, Net
	Six months ended  September 30, 2013		Six months ended September 30, 2012		September 30, 2013		March 31, 2013
United States	$	12,075,203	$	13,667,736	$	6,895,557	$	7,252,027
China	$	217,284	$	1,556,555	$	11,725	$	19,346

NOTE 16 – COMMITMENTS

We have employment agreements with our executive officers. Such agreements provide for minimum salary levels, adjusted annually, as well as for incentive bonuses that are payable if specified company goals are attained. The aggregate annual commitment at September 30, 2013 for future salaries during the next twelve months, excluding bonuses, was approximately $1,000,000.

NOTE 17 - EARNINGS PER SHARE (EPS)

Basic EPS is computed by dividing reported earnings available to stockholders by the weighted average shares outstanding. Diluted EPS also includes the effect of dilutive potential common shares. The following table provides a reconciliation of the numerators and denominators reflected in the basic and diluted loss per share computations, as required under FASB ASC 260. 

	Three Months ended September 30, 2013			Three Months ended September 30, 2012			Six Months ended September 30, 2013			Six Months ended September 30, 2012
Basic EPS
Net Loss	$	(818,670	)	$	(45,020	)	$	(2,242,575	)	$	(751,289	)
Weighted average number of shares outstanding		19,956,871			18,696,846			19,956,871			18,614,112
Basic income (loss) per share	$	(0.04	)	$	(0.00	)	$	(0.11	)	$	(0.04	)
Diluted EPS
Net Loss	$	(818,670	)	$	(45,020	)	$	(2,242,575	)	$	(751,289	)
Dilutive effect of stock options, warrants and preferred stock		--			--			--			--
Diluted weighted average shares		19,956,871			18,696,846			19,956,871			18,614,112
Diluted loss per share	$	(0.04	)	$	(0.00	)	$	(0.11	)	$	(0.04	)

All potential common share equivalents that have an anti-dilutive effect (i.e. those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS. For the three and six month periods ended September 30, 2013, there were 5,011,341 and 5,359,626 shares, respectively, and for the three and six months ended September 30, 2012 there were 5,808,674 and 6,907,806 shares, respectively, of potentially anti-dilutive stock options, warrants and convertible preferred stock, none of which were included in the EPS calculations above.  

NOTE 18 – SUBSEQUENT EVENTS

In October 2013 we completed a workforce reduction action that resulted in a 19% reduction in the work force. The cost of this action will result in a charge to operating expenses of approximately $0.1 million which will be paid out before the end of fiscal 2014. This action was prompted by management’s plan to realign our cost structure so we can return to profitability at current revenue levels.

16

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

Statement Regarding Forward Looking Disclosure

The following discussion of the results of our operations and financial condition should be read in conjunction with our condensed consolidated financial statements and the related notes herein.  This quarterly report on Form 10Q, including this section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” or MD&A, may contain predictive or “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions.  These statements are based on current expectations, estimates and projections about our business based in part on assumptions made by management.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict.  Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors.  Those factors include those risks discussed in this Item 2 “Management’s Discussion and Analysis” in this Form 10-Q and those described in any other filings which we make with the SEC.  In addition, such statements could be affected by risks and uncertainties related to recurring operating losses and the availability of appropriate financing facilities impacting our ability to continue as a going concern, to change the composition of our revenues and effectively reduce our operating expenses, our ability to generate business on an on-going basis, to obtain any required financing on favorable terms, to receive contract awards from the competitive bidding process, maintain standards to enable us to manufacture products to exacting specifications, enter new markets for our services, marketing and customer acceptance, our reliance on a small number of customers for a significant percentage of our business, competition, government regulations and requirements, pricing and development difficulties, our ability to make acquisitions and successfully integrate those acquisitions with our business, as well as general industry and market conditions and growth rates, and general economic conditions.  We undertake no obligation to publicly update or revise any forward looking statements to reflect events or circumstances that may arise after the date of this report, except as required by applicable law.  Any forward-looking statements speak only as of the date on which they are made, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this report. Investors should evaluate any statements made by us in light of these important factors.

Overview

We offer a full range of services required to transform metallic raw materials into precise finished products. Our manufacturing capabilities include: fabrication operations (cutting, press and roll forming, assembly, welding, heat treating, blasting and painting) and machining operations including CNC (computer numerical controlled) horizontal and vertical milling centers. We also provide support services to our manufacturing capabilities: manufacturing engineering (planning, fixture and tooling development, manufacturing), quality control (inspection and testing), materials procurement, production control (scheduling, project management and expediting) and final assembly.

All U.S. manufacturing is done in accordance with our written quality assurance program, which meets specific national and international codes, standards, and specifications. Ranor holds several certificates of authorization issued by the American Society of Mechanical Engineers and the National Board of Boiler and Pressure Vessel Inspectors. The standards used are specific to the customers’ needs, and our manufacturing operations are conducted in accordance with these standards.

Because our revenues are derived from the sale of goods manufactured pursuant to a contract, and we do not sell from inventory, it is necessary for us to constantly seek new contracts. There may be a time lag between our completion of one contract and commencement of work on another contract. During such periods, we may continue to incur overhead expense but with lower revenue resulting in lower operating margins. Furthermore, changes in either the scope of an existing contract or related delivery schedules may impact the revenue we receive under the contract and the allocation of manpower. Although we provide manufacturing services for large governmental programs, we usually do not work directly for the government or its agencies. Rather, we perform our services for large governmental contractors and large utility companies. However, our business is dependent in part on the continuation of governmental programs which require services and products from our customers.

We historically have experienced, and continue to experience, customer concentration. Our five largest customers collectively accounted for 71% of our revenue for fiscal 2013. For the six months ended September 30, 2013, our five largest customers accounted for approximately 69% of reported net sales.

Our contracts are generated both through negotiation with the customer and from bids made pursuant to a request for proposal. Our ability to receive contract awards is dependent upon the contracting party’s perception of such factors as our ability to perform on time, our history of performance, including quality, our financial condition and our ability to price our services competitively.  Although some of our contracts contemplate the manufacture of one or a limited number of units, we are seeking more long-term projects with a more predictable cost structure. Our sales order backlog at September 30, 2013 was approximately $17.5 million compared with a backlog of $16.4 million at March 31, 2013.  

We invested in our China subsidiary, WCMC, to meet shifting demands from key customers, and simultaneously had to weather slowdowns in our precision industrial market for alternative energy customers. The impact on our Ranor facility was significant because manufacturing for their largest customer was transferred to China. We replaced the transferred business by backfilling our Ranor facility with orders from existing and new customers that required domestic production capacity.

17

At September 30, 2013, we were in default and continue to be in default with the Loan Agreement with the Bank. At March 31, 2013, we were not in compliance with our financial covenants in the Loan Agreement, and the Bank did not agree to waive the non-compliance with the covenants. As a result, we were in default at March 31, 2013. In addition, the Bank also did not renew the revolving credit facility which expired on July 31, 2013. The Bank has the right to accelerate payment of the debt in full upon 60 days' written notice. As a consequence, all amounts under the Loan Agreement are classified as a current liability at September 30, 2013 ($5.4 million) and March 31, 2013 ($5.8 million).

These factors raise substantial doubt regarding our ability to continue as a going concern. Our financial statements do not include any adjustments that might result from the outcome of this uncertainty. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources.”

Growth Strategy

We are a contract manufacturer and we sell our services to customers in three industries: energy, naval/maritime, and precision industrial. Our strategy is to leverage our core competence as a manufacturer of high-precision, large-scale metal fabrications and machined components to optimize profitability of our current business and expand into stronger markets that have shown increasing demand. We aim to establish our expertise in program and project management and develop and expand a repeatable customer business model in our strongest markets. The following discussion addresses certain growth opportunities within the three industry groups:

Naval/Maritime

Our Ranor subsidiary performs precision fabrication and machining for the defense and aerospace industries, delivering turnkey defense components to our customers stringent design specifications, as well as quality and safety manufacturing standards specifically for defense component fabrication and machining. Defense components the Ranor team has delivered include critical sonar housings and fairings, vertical launch missile tubes, and magnetic motor system components. In addition, the team at Ranor has successfully developed new, effective approaches to fabrication that continue to be utilized at their facility and at our customer’s own defense component manufacturing facilities. We have developed and built Tier 1 and Tier 2 relationships with our customers and will continue to seek opportunities in this sector where we are in a Tier 1 or Tier 2 supplier relationship.

Over the course of the past year, we have increased our business development efforts with large prime defense contractors.  Based upon these efforts, we believe there are additional opportunities to secure increased outsourcing business with existing and new defense contractors who are actively looking to increase outsourced content on certain expanding defense programs over the next several years.  We believe that the military quality certifications we maintain and our ability to offer turn-key fabrication, machining and manufacturing services at a single facility position us as an attractive outsourcing partner for prime contractors looking to increase outsourced production.

Energy (Nuclear)

In February 2013, we completed the initial manufacture of Type B radioactive isotope transport casks on behalf of our customer, Alpha-Omega Services, Inc.  We have been working with this customer for several years while it was seeking U.S. Nuclear Regulatory Commission, or NRC, license approval of its proprietary Type B radioactive isotope transport casks.  As this customer’s cask design meets the NRC’s most recent regulatory requirements for Type B transport casks, we and our customer expect increased demand for this product as the NRC requires companies that transport radioactive isotopes to replace their existing Type B transport casks with casks that meet the latest NRC requirements.

Ranor is one of the few facilities in the United States that has the certifications required to produce the necessary components for nuclear power plants. Because of our manufacturing capabilities, our certification from the American Society of Mechanical Engineers and our historic relationships with suppliers in the nuclear power industry, we believe that we are well positioned to benefit from any increased activity in the nuclear sector. However, we cannot assure you that we will be able to develop any significant business from the nuclear industry.

Precision Industrial

For several years we have been providing production services to Mevion Medical Systems, or Mevion, for the manufacture of its proprietary proton beam radiotherapy system. Mevion received 510(k) clearance from the U.S. Food and Drug Administration, or FDA, in June 2012 to market its proton radiotherapy device.  Presently Mevion has eleven systems currently under development with customers in the U.S. In January 2013, we announced a five-year agreement with Mevion to exclusively produce precision components for Mevion’s proton beam system. During fiscal 2013, Mevion became our largest customer and accounted for $7.7 million in net sales. We expect that sales volume to Mevion will increase as Mevion further expands the market launch of its innovative proton therapy device.

18

Growing global demand for LED lighting and LED enabled products has increased the worldwide demand for Heat Exchanger Method (HEM) sapphire, a core component in high-end LED products. Accordingly, many polysilicon companies are expanding into the field of HEM sapphire and existing players in the HEM sapphire industry are expanding their production capacity. The production of HEM sapphire requires robust high temperature vacuum furnaces much like those we have been producing for the processing of polysilicon within the solar industry.

Historically, alternative energy has been our largest market served and has comprised a significant amount of annual net sales. The primary products we have manufactured for alternative energy customers, including GT Advanced Technologies, or GTAT, have been multi-crystalline and mono-crystalline solar furnaces, sapphire furnaces as well as polysilicon reactor vessels. During fiscal 2013 and 2012, the pace at which solar and sapphire manufactures increased their production capacity was slow. As a result our sales volume to customers within the alternative energy sector comprised only 28.5% of total sales for fiscal 2013.

We believe the HEM sapphire field is a growing sector where our manufacturing expertise and experience with similar products for the solar industry can be directly leveraged. We are in active dialogue with existing customers regarding our capability and capacity to manufacture furnaces for the HEM sapphire industry.

Demand in our end-use markets is sensitive to general economic conditions, competitive influences and fluctuations in inventory levels throughout the supply chain. Our sales are sensitive to the market conditions present in the industries in which the ultimate consumers operate, which in some cases have been highly cyclical and subject to substantial downturns. As a result of the cyclical nature of our markets, we have experienced and in the future we may experience, significant fluctuations in our sales and results of operations with respect to a substantial portion of our total product offering, and such fluctuations could be material and adverse to our overall financial condition, results of operations and liquidity.

Critical Accounting Policies and Estimates

The preparation of the unaudited condensed consolidated financial statements requires that we make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We base our estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We continually evaluate our estimates, including those related to contract accounting, inventories, recovery of long-lived assets, income taxes and the valuation of equity transactions. These estimates and assumptions require management’s most difficult, subjective or complex judgments. Actual results may differ under different assumptions or conditions.

Our significant accounting policies are set forth in detail in Note 2 to the 2013 Form 10-K. There were no significant changes in the critical accounting policies during the three and six months ended September 30, 2013, nor did we make any changes to our accounting policies that would have changed these critical accounting policies.

New Accounting Pronouncements

See Note 3 – Recently Issued and Adopted Accounting Pronouncements to our condensed consolidated financial statements included in this Form 10-Q for a discussion of recently adopted accounting guidance and other new accounting guidance.

Results of Operations

Our results of operations are affected by a number of external factors including the availability of raw materials, commodity prices (particularly steel), macroeconomic factors, including the availability of capital that may be needed by our customers, and political, regulatory and legal conditions in the United States and foreign markets.

Our results of operations are also affected by our success in booking new contracts and when we are able to recognize the related revenue, delays in customer acceptances of our products, delays in deliveries of ordered products and our rate of progress in the fulfillment of our obligations under our contracts. A delay in deliveries or cancellations of orders would cause us to have inventories in excess of our short-term needs, and may delay our ability to recognize, or prevent us from recognizing, revenue on contracts in our order backlog. We continue to execute to the business plan we developed early in our first fiscal quarter that has the immediate goal of stabilizing our business and realigning our cost structure so we can return to profitability, even at current lower revenue levels. We are focused on building our backlog with production orders from our key customers.At September 30, 2013 our backlog was $17.5 million compared with a backlog of $16.4 million as of March 31, 2013.

19

Three Months Ended September 30, 2013 and 2012

The following table sets forth information from our statements of operations in dollars and as a percentage of revenue: 

	Three Months Ended September 30, 2013						Three Months Ended September 30, 2012						Changes Period Ended September 30, 2013 to 2012
(dollars in thousands)	Amount			Percent			Amount			Percent			Amount			Percent
Net sales	$	5,195			100	%	$	8,078			100	%	$	(2,883	)		(36	) %
Cost of sales		4,468			86	%		6,140			76	%		(1,672	)		(27	)  %
Gross profit		727			14	%		1,938			24	%		(1,211	)		(63	) %
Selling, general and administrative		1,484			29	%		1,924			24	%		(440	)		(23	) %
(Loss) Income from operations		(757	)		(15	)%		14			0	%		(771	)		nm	%
Other income (expense):
Other income (expense), net		6			--	%		4			--	%		2			50	%
Interest expense		(67	)		(1	)%		(74	)		(1	)%		7			(9	)  %
Total other expense, net		(61	)		(1	)%		(70	)		(1	)%		9			(13	)  %
Loss before income taxes		(818	)		(16	)%		(56	)		(1	)%		(762	)		nm	%
Income tax benefit		--			--	%		(11	)		--	%		11			nm	%
Net Loss	$	(818	)		(16	)%	$	(45	)		(1	)%	$	(773	)		nm	%

Net Sales

For the three months ended September 30, 2013, net sales decreased by $2.9 million, or 36%, to $5.2 million. Net sales decreased in the precision industrial markets by $3.5 million on lower shipments of medical components, sapphire production chambers and pressure vessels. This amount was partially offset by increased net sales to our naval/maritime and energy customers of $0.5 and $0.1 million. For the three months ended September 30, 2013, net sales originating at our WCMC division totaled $0.2 million compared with $1.1 million in the three months ended September 30, 2012, as a result of weak demand for sapphire production chambers from our largest customer in China. The increases and decreases in net sales are reflective of the frequent changes in the order flow that we see from our customers as they gauge market demand for new and existing products.

Cost of Sales and Gross Margin

Our cost of sales for the three months ended September 30, 2013 decreased by $1.7 million or 27%, on significantly lower sales volume.  Gross margins during the three months ended September 30, 2013 were 14.0% compared with 24.0% for the same period in fiscal 2013. Gross margin in any reporting period is impacted by the mix of services we provide on projects completed and in-process within that period. Certain low margin projects and contract losses dampened our margins in the quarter. We recorded $0.8 million of new contract losses during the second quarter of fiscal 2014 compared with contract losses of $0.1 million recorded during the same quarter one year ago. The majority of the contract losses recorded during three months ended September 30, 2013 are from the first units of base components being manufactured for customers by our Ranor subsidiary.

Selling, General and Administrative Expenses

Total SG&A expenses for the three months ended September 30, 2013 were $1.5 million compared with $1.9 million for the same period in fiscal 2013, representing a decrease of $0.4 million or 23%.  Lower spending of $0.1 million for compensation and benefits, $0.1 million for outside services, $0.1 million for travel and business expenses, and $0.1 million for other general and administrative expenses in fiscal 2014 contributed to the decrease.

Other Income (Expense)

The following table reflects other income (expense) and interest expense for the three months ended September 30:

(dollars in thousands)	2013			2012			$ Change		% Change
Other income (expense), net	$	6		$	4		$	2		50	%
Interest expense	$	(57	)	$	(63	)	$	6		(9)	%
Interest expense: non-cash	$	(10	)	$	(11	)	$	1		(9)	%

20

Interest expense for the three months ended September 30, 2013 decreased when compared with the same prior year period as our average levels of debt continued to decrease as we pay down principal. Non –cash interest expense reflects the amortization of deferred loan costs in connection with our Series A Bonds and Series B Bonds.

Income Taxes

For the three months ended September 30, 2013, we recorded zero tax expense or benefit.  For the three months ended September 30, 2012, we recorded a tax benefit of $11,342. The lack of a tax benefit for fiscal 2014 was primarily the result of maintaining a full valuation allowance on our net deferred tax assets. A valuation allowance must be established for deferred tax assets when it is more likely than not that they will not be realized. The assessment was based on the weight of negative evidence at the balance sheet date, our recent operating losses and unsettled circumstances that, if unfavorably resolved, would adversely affect future operations and profit levels. We regularly assess the effects resulting from these factors to determine the adequacy of our provision for income taxes.

Our future effective tax rate would be affected if earnings were lower than anticipated in countries where we have lower statutory rates and higher than anticipated in countries where we have higher statutory rates, by changes in the valuation of our deferred tax assets and liabilities, or by changes in tax laws, regulations, accounting principles, or interpretations thereof.

Net Loss

As a result of the foregoing, our net loss was $0.8 million or $0.04 per share basic and fully diluted, for the three months ended September 30, 2013, as compared to net loss of $45,020 or $0.00 per share basic and fully diluted for the three months ended September 30, 2012.

Six Months Ended September 30, 2013 and 2012

The following table sets forth information from our statements of operations for the six months ended September 30, 2013 and 2012, in dollars and as a percentage of revenue:   

	Six Months Ended September 30, 2013						Six Months Ended September 30, 2012						Changes Period Ended September 30, 2013 to 2012
(dollars in thousands)	Amount			Percent			Amount			Percent			Amount			Percent
Net sales	$	12,292			100	%	$	15,224			100	%	$	(2,932	)		(19	)  %
Cost of sales		11,144			91	%		12,180			80	%		(1,036	)		(8	)  %
Gross profit		1,148			9	%		3,044			20	%		(1,896	)		(62	)  %
Selling, general and administrative		3,255			26	%		3,925			26	%		(670	)		(17	)  %
Loss from operations		(2,107	)		(17	) %		(881	)		(6	) %		(1,226	)		nm	%
Other income		2			-	%		5			--	%		(3	)		(60	)  %
Interest expense		(138	)		(1	) %		(154	)		(1	) %		16			(10	)  %
Total other expense, net		(136	)		(1	) %		(149	)		(1	) %		13			(9	)  %
Loss before income taxes		(2,243	)		(18	) %		(1,030	)		(7	) %		(1,213	)		nm	%

Income tax benefit		--		--	%		279		(2	) %		(279	)	nm	%
Net Loss	$	(2,243	)	(18	) %	$	(751	)	(5	) %	$	(1,492	)	nm	%
nm - not meaningful

Net Sales

Net sales decreased by $2.9 million, or 19%, to $12.2 million for the six months ended September 30, 2012 when compared to the same period last year. We recorded lower revenue of $2.8 million in the Precision industrial sector primarily on lower shipments of sapphire production chambers and medical components. We also recorded lower revenue of $0.2 million on customer projects in the Naval/Maritime sector, offset in part by increased net sales to our customers in the Energy markets of $0.1 million. The increases and decreases in net sales are reflective of the frequent changes in orders we see from our customers as they gauge customer demand for new and existing products.

Cost of Sales and Gross Margin

Our cost of sales for the six months ended September 30, 2013 decreased by $1.0 million to $11.1 million on lower sales volume. Gross margins were 9.3% and 20.0% for the same comparable periods, respectively. Gross profit was $1.1 million compared with $3.0 million for the six month periods ended September 30, 2013 and September 30, 2012, respectively. Gross margin in any reporting period is impacted by the mix of services we provide on projects completed within that period. Certain low margin projects and contract losses dampened our margins in the quarter. Gross profit for the six months period ended September 30, 2013 included additional contract losses of approximately $1.5 million, a majority of which were incurred on the initial units of base components manufactured by our Ranor subsidiary. These components were initiated during the first quarter of fiscal 2014 and are expected to be completed and shipped before the end of our first quarter fiscal 2015.

21

Selling, General and Administrative Expenses

SG&A expenses for the six months ended September 30, 2013 were $3.2 million compared to $3.9 million for six months ended September 30, 2012, representing a decrease of $0.7 million or 17%.  SG&A was 26.5% and 25.8% as a percentage of net sales for the same period in fiscal 2014 and 2013, respectively.  Primary drivers of this decrease in expense were reduced spending of $0.3 million for compensation and benefits, $0.2 million for outside services, and $0.2 million for travel and business expenses in fiscal 2014.

Interest Expense

The following table reflects other income and interest expense for the six months ended September 30:

	2013			2012			$ Change			% Change
Interest income, other	$	2		$	5		$	(3	)		(60	) %
Interest expense	$	(122	)	$	(142	)	$	20			(14	) %
Interest expense: non-cash	$	(16	)	$	(12	)	$	(4	)		33	%

Interest expense decreased by 11% or $16,712 for the six months ended September 30, 2013 when compared with the same period in fiscal 2012 due to lower average levels of debt.  

Income Taxes

For the six months ended September 30, 2013, we recorded zero tax expense or benefit. For the six months ended September 30, 2012, we recorded a tax benefit of $278,599. The lack of a tax benefit for fiscal 2014 was primarily the result of maintaining a full valuation allowance on our net deferred tax assets. A valuation allowance must be established for deferred tax assets when it is more likely than not that they will not be realized. The assessment was based on the weight of negative evidence at the balance sheet date, our recent operating losses and unsettled circumstances that, if unfavorably resolved, would adversely affect future operations and profit levels. We regularly assess the effects resulting from these factors to determine the adequacy of our provision for income taxes.

Our future effective tax rate would be affected if earnings were lower than anticipated in countries where we have lower statutory rates and higher than anticipated in countries where we have higher statutory rates, by changes in the valuation of our deferred tax assets and liabilities, or by changes in tax laws, regulations, accounting principles, or interpretations thereof.

Net Loss

As a result of the factors described above, our net loss was $2.2 million or $0.11 per share basic and fully diluted respectively, for the six months ended September 30, 2013, compared to net income of $0.8 million, or $0.04 per share basic and fully diluted, for the six months ended September 30, 2012.

Liquidity and Capital Resources

At September 30, 2013, we were in default and continue to be in default with the Loan Agreement with the Bank. At March 31, 2013, we were not in compliance with the fixed charges and interest coverage financial covenants under the Loan Agreement, and the Bank did not agree to waive our non-compliance with the covenants. In addition, the Bank did not renew the revolving credit facility which expired on July 31, 2013. The Bank has the right to accelerate payment of the debt in full upon 60 days' written notice. As a consequence, all amounts under the Loan Agreement are classified as a current liability at September 30, 2013 ($5.4 million) and March 31, 2013 ($5.8 million). The Bank continues to evaluate its course of action and has not yet demanded repayment. We continue to make payments pursuant to the terms of the Loan Agreement. If the Bank were to make such a demand for repayment, we would be unable to pay the obligation as we do not have existing facilities or sufficient cash on hand to satisfy these obligations and would need to seek alternative financing. The covenants under the loan agreement are no longer being tested on a monthly, quarterly or annual basis.

22

We have incurred an operating loss of $2.2 million for the six months ended September 30, 2013, and $2.4 million and $2.1 million for the fiscal years ended March 31, 2013 and 2012, respectively. At September 30, 2013, we had cash and cash equivalents of $1.4 million, of which $0.1 million is located in China and which we may not be able to repatriate for use in the U.S. without undue cost or expense, if at all. We borrowed $0.5 million under our revolving line of credit during the three months ended March 31, 2013, and repaid this borrowing in full in July 2013. In addition, we have $0.9 million of restricted cash with the Bank (included in our other current assets) that could be used toward satisfying our obligation under the Loan Agreement.

These factors raise substantial doubt about our ability to continue as a going concern. In order for us to continue operations beyond the next twelve months and be able to discharge our liabilities and commitments in the normal course of business, we must secure long-term financing on terms consistent with our business plans. In addition, we must increase our backlog and change the composition of our revenues to focus on recurring unit of delivery projects rather than custom first article and prototyping projects which do not efficiently use our manufacturing capacity, and reduce our operating expenses to be in line with current business conditions in order to increase profit margins and decrease the amount of cash used in operations. If successful in changing the composition of revenue and reducing costs, we expect that fiscal 2014 operating results will reflect positive operating cash flows. However, we plan to closely monitor our expenses and, if required, will further reduce operating costs and capital spending to enhance liquidity.

The condensed consolidated financial statements for the six months ended September 30, 2013, and for the year ended March 31, 2013, were prepared on the basis of a going concern which contemplates that we will be able to realize assets and discharge liabilities in the normal course of business. Accordingly, they do not give effect to adjustments that would be necessary should we be required to liquidate assets. Our ability to satisfy our total current liabilities of $10.1 million at September 30, 2013 and to continue as a going concern is dependent upon the availability of and our ability to timely secure long-term financing and the successful execution of our operating plan. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.

Our failure to obtain new or additional financing could impair our ability to both serve our existing customer base and develop new customers and could result in our failure to continue to operate as a going concern. To the extent that we require new or additional financing, we cannot assure you that we will be able to get such financing on terms equal to or better than the terms of our Loan Agreement. If we are unable to raise funds through a credit facility, it may be necessary for us to conduct an offering of debt and/or equity securities on terms which may be disadvantageous to us or have a negative impact on our outstanding securities and the holders of such securities.  In the event of an equity offering, it may be necessary that we offer such securities at a price that is significantly below our current trading levels which may result in substantial dilution to our investors that do not participate in the offering and a new low trading level for our common stock.

Our liquidity is highly dependent on our available financing facilities and ability to improve our gross profit and operating income. If we successfully secure an acceptable financing facility and execute on our business plans, then we believe that our available cash, together with additional reductions in operating costs and capital expenditures, will be sufficient to fund our operations, capital expenditures and principal and interest payments under our debt obligations through the next twelve months.

At September 30, 2013, we had working capital of $1.6 million as compared with working capital of $3.1 million at March 31, 2013, representing a decrease of $1.5 million or 49%. The following table sets forth information as to the principal changes in the components of our working capital:

(dollars in thousands)	September 30, 2013		March 31, 2013		Change Amount			Percentage Change
Cash and cash equivalents	$	1,532	$	3,075	$	(1,543	)		(50	) %
Accounts receivable, net		2,690		4,331		(1,641	)		(38	) %
Costs incurred on uncompleted contracts		5,064		4,298		766			18	%
Inventory - raw materials		355		354		1			-	%
Income taxes receivable		374		374		--			-	%
Current deferred tax assets		256		256		--			-	%
Other current assets		1,388		1,578		(190	)		(12	) %
Accounts payable		1,248		2,537		(1,289	)		(51	) %
Accrued expenses		2,502		1,875		627			33	%
Accrued taxes payable		232		232		--			-	%
Deferred revenues		677		253		424			167	%
Current maturity of long-term debt		5,418		5,784		(366	)		(6	) %
Short-term revolving line of credit		--		500		(500	)		(100	) %

23

The following table summarizes our primary cash flows for the periods presented:

(dollars in thousands)	Sept. 30, 2013			Sept. 30, 2012			Change Amount
Cash flows provided by (used in):
Operating activities	$	(616	)	$	78		$	(694	)
Investing activities		(54	)		(75	)		21
Financing activities		(875	)		(684	)		(191	)
Effects of foreign exchange rates on cash		2			(4	)		6
Net decrease in cash and cash equivalents	$	(1,543	)	$	(685	)	$	(858	)

Operating activities

Cash used in operations for the six months ended September 30, 2013 was $0.6 million compared with cash provided by operations of $78,277 for the six months ended September 30, 2012. Cash provided by our customer accounts receivables collections during the six month period were used for work-in-progress spending, and to pay accounts payable and principal on short and long-term debt.

When compared to the same six month period in fiscal 2013, cash flows used in operations in fiscal 2014 were impacted by significant reductions in accounts payable as we paid suppliers and vendors for materials and services. We also received fewer progress payments on customer projects than last year. Cash provided by operations for the same comparable period in fiscal 2013 were positively impacted by the receipt of progress payments and deposits of approximately $3.0 million. Our cash flows can fluctuate significantly from period to period as the composition of our revenues changes between unit of delivery projects and first article production and prototyping projects.

Investing activities

The periods ended September 30, 2013 and 2012, were marked by cash outflows for capital spending of $53,941 and $75,109, respectively.

Financing activities

For the six month period ended in fiscal 2014, cash used in financing activities was $0.9 million to make principal payments on our outstanding debt. For the comparable period end in fiscal 2013, cash used in financing activities was $0.7 million related to principal payments for long-term debt. Obligations under the Term Note, Revolving Note, Capital Expenditure Note and Staged Advance Note are guaranteed by TechPrecision and Ranor. Collateral securing such notes comprises all personal property of TechPrecision and Ranor, including cash, accounts receivable, inventories, equipment, financial and intangible assets. We have no off-balance sheet assets or liabilities.

All of the above activity resulted in a net decrease in cash for fiscal 2014 of $1.5 million, compared with a net decrease in cash of $0.6 million for fiscal 2013.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As of September 30, 2013, we carried out an evaluation, under the supervision and with the participation of management, including our  executive chairman and chief financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended, or Exchange Act. Based on the evaluation, our executive chairman and chief financial officer have concluded that, as of September 30, 2013, our disclosure controls and procedures and internal control over financial reporting were not effective because of the material weakness described in Item 9A of our Annual Report on Form 10-K for the year ended March 31, 2013 as filed with the SEC on August 16, 2013.

Disclosure controls and procedures are designed with the objective of ensuring that (i) information required to be disclosed in our reports filed under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms and (ii) information is accumulated and communicated to management, including our executive chairman and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.

We are making progress remediating the material weakness identified in our Annual Report on Form 10-K for the year ended March 31, 2013. Notwithstanding the material weakness described in Item 9A of the 2013 Form 10-K, we believe our condensed consolidated statements presented in this Quarterly Report on Form 10-Q fairly represent, in all material respects, our financial position, results of operations and cash flows for all periods presented herein.

24

Changes in Internal Controls

Except as identified below, there has been no change to our internal controls over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act) during the six months ended September 30, 2013, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. During the six months ended September 30, 2013 we began implementing stronger manual controls that support our financial reporting process by 1) providing guidelines for account reconciliations and enhancing documentation to support sub-ledger account reconciliations. As we continue to remediate the material weakness described above, we will determine the appropriate complement of corporate and divisional accounting personnel required to consistently operate management review controls.

PART II. OTHER INFORMATION

Item 1A. Risk Factors

There have been no material changes to the risk factors discussed in Part I, "Item 1A. Risk Factors," in the 2013 Form 10-K.  You should carefully consider the risks described in our 2013 Form 10-K which could materially affect our business, financial condition or future results.  The risks described in our 2013 Form 10-K are not the only risks we face.  Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.  If any of the risks actually occur, our business, financial condition and/or results of operations could be negatively affected.

Item 6. Exhibits

Exhibit No.	Description
31.1	Rule 13a-14(a) certification of chief executive officer
31.2	Rule 13a-14(a) certification of chief financial officer
32.1	Section 1350 certification of chief executive and chief financial officers
101.INS	101.INS XBRL Instance Document
101.SCH 101.CAL 101.LAB 101.PRE 101.DEF 101.CAL	101.SCH XBRL Taxonomy Extension Schema Document 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document 101.LAB XBRL Taxonomy Extension Labels Linkbase Document 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document 101.DEF XBRL Taxonomy Extension Definition Linkbase Document 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document

25

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	TECHPRECISION CORPORATION (Registrant)
Dated:  November 14, 2013		/s/ Richard F. Fitzgerald
		Richard F. Fitzgerald Chief Financial Officer (duly authorized officer and principal financial officer)

26

EXHIBIT INDEX

Exhibit No.	Description
31.1	Rule 13a-14(a) certification of chief executive officer
31.2	Rule 13a-14(a) certification of chief financial officer
32.1	Section 1350 certification of chief executive and chief financial officers
101.INS	101.INS XBRL Instance Document
101.SCH 101.CAL 101.LAB 101.PRE 101.DEF 101.CAL	101.SCH XBRL Taxonomy Extension Schema Document 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document 101.LAB XBRL Taxonomy Extension Labels Linkbase Document 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document 101.DEF XBRL Taxonomy Extension Definition Linkbase Document 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document

27

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Leonard M. Anthony, certify that:

1. I have reviewed this quarterly report on Form 10-Q of TechPrecision Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: November 14, 2013	/s/ Leonard M. Anthony
	Leonard M. Anthony

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Richard F. Fitzgerald, certify that:

1. I have reviewed this quarterly report on Form 10-Q of TechPrecision Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: November 14, 2013	/s/ Richard F. Fitzgerald
	Richard F. Fitzgerald

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of TechPrecision Corporation (Company) on Form 10-Q for the three months ended September 30, 2013, as filed with the Securities and Exchange Commission on the date hereof (Report), I, Leonard M. Anthony, the Executive Chairman, and I, Richard F. Fitzgerald, the Chief Financial Officer of the Company, do hereby certify pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 14, 2013	/s/ Leonard M. Anthony
	Leonard M. Anthony
Dated: November 14, 2013	/s/ Richard F. Fitzgerald
	Richard F. Fitzgerald

XML

CAPITAL STOCK

6 Months Ended

Sep. 30, 2013

CAPITAL STOCK

CAPITAL STOCK

NOTE 12 – CAPITAL STOCK

Preferred Stock

We have 10,000,000 authorized shares of preferred stock and the Board of Directors has broad power to create one or more series of preferred stock and to designate the rights, preferences, privileges and limitation of the holders of such series. The Board of Directors has created one series of preferred stock - the Series A Convertible Preferred Stock.

Each share of Series A Convertible Preferred Stock was initially convertible into one share of common stock. As a result of our failure  to meet certain levels of earnings before interest, taxes, depreciation and amortization for the years ended March 31, 2006 and 2007, the conversion rate changed, and, at December 31, 2009, each share of Series A Convertible Preferred Stock was convertible into 1.3072 shares of common stock, with an effective conversion price of $0.218.  Based on the current conversion ratio, there were 7,232,735 common shares underlying the Series A Convertible Preferred Stock as of September 30, 2013 and March 31, 2013.

Upon any liquidation we would be required to pay $0.285 for each share of Series A Convertible Preferred Stock. The payment will be made before any payment to holders of any junior securities and after payment to holders of securities that are senior to the Series A Convertible Preferred Stock.

During fiscal 2013 1,502,984 shares of Series A Convertible Preferred Stock were converted into 1,964,694 shares of common stock. We had 5,532,998 shares of Series A Convertible Preferred Stock outstanding at September 30, 2013 and March 31, 2013.

Common Stock Purchase Warrants

On February 15, 2011, we entered into a contract with a third party pursuant to which we issued two-year warrants to purchase 100,000 shares of common stock at an exercise price of $1.65 per share. Using the Black-Scholes options pricing formula assuming a risk free rate of 0.30%, volatility of 79%, an expected term of one year, and the price of the common stock on February 15, 2011 of $1.65 per share, the value of the warrant was calculated at $51,428, or $0.51 per share issuable upon exercise of the warrant. Since the warrant permitted delivery of unregistered shares, we have control in settling the contract by issuing equity. The cost of warrants was charged to selling, general and administrative. The warrants expired on February 14, 2013 and at March 31, 2013 there were no warrants outstanding.

Common Stock

We had 90,000,000 authorized common shares at September 30, 2013 and March 31, 2013, and there were 19,956,871 shares of common stock outstanding at September 30, 2013 and March 31, 2013.

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (USD $)	3 Months Ended		6 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
Net sales	$ 5,195,795	$ 8,078,552	$ 12,292,487	$ 15,224,291
Cost of sales	4,468,523	6,140,187	11,144,972	12,180,487
Gross profit	727,272	1,938,365	1,147,515	3,043,804
Selling, general and administrative	1,484,487	1,924,079	3,254,569	3,924,599
(Loss) income from operations	(757,215)	14,286	(2,107,054)	(880,795)
Other income, expense	6,985	2,558	(567)	2,511
Interest expense	(67,646)	(74,394)	(137,773)	(154,485)
Interest income	(794)	1,188	2,819	2,881
Total other expense, net	(61,455)	(70,648)	(135,521)	(149,093)
Loss before income taxes	(818,670)	(56,362)	(2,242,575)	(1,029,888)
Income tax benefit	0	(11,342)	0	(278,599)
Net loss	(818,670)	(45,020)	(2,242,575)	(751,289)
Other comprehensive (loss) income, before tax:
Change in unrealized loss on cash flow hedges	(7,476)	(8,552)	(117,813)	(79,143)
Foreign currency translation adjustments	(184)	26,214	(2,396)	14,111
Other comprehensive income (loss), before tax	(7,660)	17,662	(120,209)	(65,032)
Net tax benefit of other comprehensive loss items		(3,374)		(31,219)
Other comprehensive (loss) income, net of tax	(7,660)	21,036	(120,209)	(33,813)
Comprehensive loss	$ (826,330)	$ (23,984)	$ (2,362,784)	$ (785,102)
Net loss per share (basic) (in dollars per share)	$ (0.04)	$ 0.00	$ (0.11)	$ (0.04)
Net loss per share (diluted) (in dollars per share)	$ (0.04)	$ 0.00	$ (0.11)	$ (0.04)
Weighted average number of shares outstanding (basic) (in shares)	19,956,871	18,696,846	19,956,871	18,614,112
Weighted average number of shares outstanding (diluted) (in shares)	19,956,871	18,696,846	19,956,871	18,614,112

XML

COSTS INCURRED ON UNCOMPLETED CONTRACTS

6 Months Ended

Sep. 30, 2013

COSTS INCURRED ON UNCOMPLETED CONTRACTS

COSTS INCURRED ON UNCOMPLETED CONTRACTS

NOTE 5 – COSTS INCURRED ON UNCOMPLETED CONTRACTS

	September 30, 2013			March 31, 2013
Cost incurred on uncompleted contracts, beginning balance	$	6,180,839		$	10,879,743
Total cost incurred on contracts during the period	11,190,624			21,215,441
Less cost of sales, during the period	(11,144,972		)	(25,914,345		)
Cost incurred on uncompleted contracts, ending balance	$	6,226,491		$	6,180,839
Billings on uncompleted contracts, beginning balance	$	1,882,546		$	6,969,717
Plus: Total billings incurred on contracts, during the period	11,572,396			27,385,748
Less: Contracts recognized as revenue, during the period	(12,292,487		)	(32,472,919		)
Billings on uncompleted contracts, ending balance	$	1,162,455		$	1,882,546
Cost incurred on uncompleted contracts, ending balance	$	6,226,491		$	6,180,839
Billings on uncompleted contracts, ending balance	1,162,455			1,882,546
Costs incurred on uncompleted contracts, in excess of progress billings	$	5,064,036		$	4,298,293

Contract costs consist primarily of labor and materials and related overhead, to the extent that such costs are recoverable. Revenues associated with these contracts are recorded only when the amount of recovery can be estimated reliably and realization is probable. As of September 30, 2013 and March 31, 2013, we had deferred revenues totaling $677,907 and $253,813, respectively. Deferred revenues represent customer prepayments on their contracts and completed contracts on which all revenue recognition criteria were not met. We record provisions for losses within costs of sales in our condensed consolidated statement of operations and comprehensive loss. We also receive advance billings and deposits representing down payments for acquisition of materials and progress payments on contracts. The agreements with our customers allow us to offset the progress payments against the costs incurred.

We continued to incur losses on a certain customer projects at September 30, 2013. These losses are included in our statement of operations for the six months ended September 30, 2013. We have recorded $1.4 million of contract losses in our financial statements for the six months ended September 30, 2013. We are in dialogue with customers to remedy project design and production activities that have caused these losses. When product design and production require alteration we endeavor to secure change orders from our customers.

XML

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)

6 Months Ended

Sep. 30, 2013

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

Basis of Presentation

The accompanying condensed consolidated financial statements include the accounts of TechPrecision, WCMC and Ranor. Intercompany transactions and balances have been eliminated in consolidation. The accompanying condensed consolidated balance sheet as of September 30, 2013, the condensed consolidated statements of operations and comprehensive loss for the three and six months periods ended September 30, 2013 and 2012, and the condensed consolidated statements of cash flows for the six months ended September 30, 2013 and 2012 are unaudited, but in the opinion of management, include all adjustments that are necessary for a fair presentation of our financial statements for interim periods in accordance with U.S. Generally Accepted Accounting Principles, or U.S. GAAP. All adjustments are of a normal, recurring nature, except as otherwise disclosed. The results of operations for an interim period are not necessarily indicative of the results of operations to be expected for the fiscal year.

The Notes to Condensed Consolidated Financial Statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission, or SEC, for Quarterly Reports on Form 10-Q. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. These unaudited financial statements and related notes should be read in conjunction with our consolidated financial statements included with our Annual Report on Form 10-K, or 2013 Form 10-K, filed with the SEC for the year ended March 31, 2013.

XML

STOCK BASED COMPENSATION

6 Months Ended

Sep. 30, 2013

STOCK BASED COMPENSATION

STOCK BASED COMPENSATION

NOTE 13 – STOCK BASED COMPENSATION

In 2006, the directors adopted, and the stockholders approved, the 2006 TechPrecision Corporation Long-term Incentive Plan, or, as amended, the Plan. The Plan provides for the grant of incentive and non-qualified options, stock grants, stock appreciation rights and other equity-based incentives to employees, including officers, and consultants. The Plan is to be administered by a committee of not less than two directors each of whom is to be an independent director. In the absence of a committee, the Plan is administered by the Board of Directors. Independent directors are not eligible for discretionary options. The maximum number of shares of common stock that may be issued under the Plan is 3,300,000 shares.

Pursuant to the Plan, each newly elected independent director receives at the time of his or her election, a five-year option to purchase 50,000 shares of common stock at the market price on the date of his or her election.  In addition, the Plan provides for the annual grant of an option to purchase 10,000 shares of common stock on July 1st of each year following the third anniversary of the date of his or her first election.

On June 13, 2013 and pursuant to the Plan, we granted stock options to our Executive Chairman to purchase 100,000 shares of common stock at an exercise price of $0.67 per share, the fair market value on the date of grant. The options have a term of ten years and will vest in three equal installments on each of the grant date and first two anniversaries of the grant date subject to continuous service as a member of the board through the second anniversary of the grant date.

On June 13, 2013 and pursuant to the Plan, we granted stock options to certain executives to purchase 300,000 shares of common stock at an exercise price of $0.67 per share, the fair market value on the date of grant. The options have a term of ten years and will vest in three equal annual installments starting on the first anniversary of the grant date subject to continuous employment service.

The fair value was estimated using the Black-Scholes option-pricing model based on the closing stock prices at the grant date and the weighted average assumptions specific to the underlying options. Expected volatility assumptions are based on the historical volatility of our common stock. The risk-free interest rate was selected based upon yields of five-year U.S. Treasury issues. We use the simplified method for all grants to estimate the expected term of the option. We assume that stock options will be exercised evenly over the period from vesting until the awards expire. As such, the assumed period for each vesting tranche is computed separately and then averaged together to determine the expected term for the award. Because of our limited stock exercise activity we did not rely on our historical exercise data. The assumptions utilized for option grants during the six months ended September 30, 2013 were 100.7% for volatility, a risk free interest rate of 1.1%, and expected term of approximately six years. At September 30, 2013, 1,268,506 shares of common stock were available for grant under the Plan. The following table summarizes information about options for the most recent annual income statements presented:

	Number Of		Weighted Average		Aggregate Intrinsic		Weighted Average Remaining Contractual Life
	Options		Exercise Price		Value		(in years)
Outstanding at 3/31/2013	2,484,000		$	1.027	$	776,475	9.07
Granted	400,000		$	0.670	—		—
Forfeited	(1,331,000	)	$	0.952	—		—
Outstanding at 9/30/2013	1,553,000		$	0.970	$	17,750	7.17
Vested or expected to vest 9/30/2013	1,553,000		$	0.970	$	17,750	7.17
Exercisable at 9/30/2013	1,001,667		$	0.986	$	17,750	5.22

At September 30, 2013 there was $350,652 of total unrecognized compensation cost related to stock options. These costs are expected to be recognized over the next four years. The total fair value of shares vested during the six months ended September 30, 2013 was $174,905.

The following table summarizes the activity of our stock options outstanding but not vested for the six months ended September 30, 2013:

	Number of Options		Weighted Average
Outstanding at 3/31/2013	854,334		$	1.249
Granted	400,000		$	0.670
Vested	(155,334	)	$	1.126
Forfeited	(547,667	)	$	1.171
Outstanding at 9/30/2013	551,333		$	0.941

We made a discretionary grant outside of the Plan on June 13, 2013 of 200,000 options at an exercise price of $0.67 per share, the fair market value on the date of grant, to our non-employee directors in recognition of their additional services while we seek a permanent chief executive officer. The options have a term of ten years and will vest in three equal installment amounts on each of the grant date and first anniversaries of the grants and are subject to continuous service as members of the board through the second anniversary of the grant date. Although the grants were made outside of the Plan, the terms of the options are the same as those issued under the Plan.

XML

EARNINGS PER SHARE (EPS) (Details) (USD $)	3 Months Ended		6 Months Ended		12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Mar. 31, 2013	Mar. 31, 2012
Basic EPS
Net Loss (in dollars)	$ (818,670)	$ (45,020)	$ (2,242,575)	$ (751,289)	$ (2,400,000)	$ (2,100,000)
Weighted average number of shares outstanding	19,956,871	18,696,846	19,956,871	18,614,112
Basic income (loss) per share (in dollars per share)	$ (0.04)	$ 0.00	$ (0.11)	$ (0.04)
Diluted EPS
Net Loss (in dollars)	$ (818,670)	$ (45,020)	$ (2,242,575)	$ (751,289)	$ (2,400,000)	$ (2,100,000)
Dilutive effect of stock options, warrants and preferred stock (in shares)			0
Diluted weighted average shares	19,956,871	18,696,846	19,956,871	18,614,112
Diluted Loss per share (in dollars per share)	$ (0.04)	$ 0.00	$ (0.11)	$ (0.04)
Antidilutive securities excluded from computation of earnings per share amount (in shares)	5,011,341	5,808,674	5,359,626	6,907,806

XML

ACCRUED EXPENSES (Details) (USD $)	Sep. 30, 2013	Mar. 31, 2013
ACCRUED EXPENSES
Accrued compensation	$ 413,901	$ 668,038
Interest rate swaps market value	271,168	388,982
Customer deposits		236,000
Other	118,892	311,732
Total	$ 803,961	$ 1,604,752

XML

OTHER CURRENT ASSETS (Tables)

6 Months Ended

Sep. 30, 2013

OTHER CURRENT ASSETS

Schedule of other current assets

	September 30, 2013		March 31, 2013
Payments advanced to suppliers	$	229,449	$	267,513
Prepaid insurance	151,316		187,086
Collateral deposits (see Note 8)	927,462		1,032,348
Deferred loan costs, net of amortization	42,201		57,930
Other	37,965		33,607
Total	$	1,388,393	$	1,578,484

XML

COSTS INCURRED ON UNCOMPLETED CONTRACTS (Tables)

6 Months Ended

Sep. 30, 2013

COSTS INCURRED ON UNCOMPLETED CONTRACTS

Schedule of costs incurred on uncompleted contracts

	September 30, 2013			March 31, 2013
Cost incurred on uncompleted contracts, beginning balance	$	6,180,839		$	10,879,743
Total cost incurred on contracts during the period	11,190,624			21,215,441
Less cost of sales, during the period	(11,144,972		)	(25,914,345		)
Cost incurred on uncompleted contracts, ending balance	$	6,226,491		$	6,180,839
Billings on uncompleted contracts, beginning balance	$	1,882,546		$	6,969,717
Plus: Total billings incurred on contracts, during the period	11,572,396			27,385,748
Less: Contracts recognized as revenue, during the period	(12,292,487		)	(32,472,919		)
Billings on uncompleted contracts, ending balance	$	1,162,455		$	1,882,546
Cost incurred on uncompleted contracts, ending balance	$	6,226,491		$	6,180,839
Billings on uncompleted contracts, ending balance	1,162,455			1,882,546
Costs incurred on uncompleted contracts, in excess of progress billings	$	5,064,036		$	4,298,293

XML

SEGMENT INFORMATION (Details) (USD $)	3 Months Ended		6 Months Ended		12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013 item	Sep. 30, 2012	Mar. 31, 2013
SEGMENT INFORMATION
Number of operating segments			1
SEGMENT INFORMATION
Net Sales	$ 5,195,795	$ 8,078,552	$ 12,292,487	$ 15,224,291	$ 32,472,919
Property, Plant and Equipment, Net	6,907,282		6,907,282		7,300,248
United States
SEGMENT INFORMATION
Net Sales			12,075,203	13,667,736
Property, Plant and Equipment, Net	6,895,557		6,895,557		7,252,027
China
SEGMENT INFORMATION
Net Sales			217,284	1,556,555
Property, Plant and Equipment, Net	$ 11,725		$ 11,725		$ 19,346

XML

DESCRIPTION OF BUSINESS (Details) (USD $)	3 Months Ended		6 Months Ended		12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Mar. 31, 2013	Mar. 31, 2012
DESCRIPTION OF BUSINESS
Period of written notice to accelerate payment of the debt in full in case of default			60 days
Amounts reclassified as a current liability due to default, under the loan and security agreement	$ 5,400,000		$ 5,400,000		$ 5,800,000
DESCRIPTION OF BUSINESS
Net loss	(818,670)	(45,020)	(2,242,575)	(751,289)	(2,400,000)	(2,100,000)
Cash and cash equivalents	1,532,026	2,138,756	1,532,026	2,138,756	3,075,376	2,823,485
Cash deposits located in China, which may not be able to be repatriated for use in the U.S. without undue cost or expense	100,000		100,000
Revolving credit facility					500,000
Restricted cash with the Bank that could be used toward satisfying obligation under the loan agreement	900,000		900,000
Total current liabilities	$ 10,078,423		$ 10,078,423		$ 11,182,900

XML

INCOME TAXES (Details) (USD $)	3 Months Ended		6 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
INCOME TAXES
Income tax expense (benefit)	$ 0	$ (11,342)	$ 0	$ (278,599)
Federal net operating loss carry-forward	$ 2,300,000		$ 2,300,000

XML

SUBSEQUENT EVENTS (Details) (Subsequent event, Workforce reduction, USD $) In Millions, unless otherwise specified	1 Months Ended
	Oct. 31, 2013
Subsequent event | Workforce reduction
Subsequent events
Percentage reduction in the work force	19.00%
Cost due to reduction in the work force	$ 0.1

XML

CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS (Tables) (Customer concentration)

6 Months Ended

Sep. 30, 2013

Receivable balance

Concentration of credit risk and major customers

Schedule of concentration of risk by factors

	September 30, 2013				March 31, 2013
Customer	Dollars		Percent		Dollars		Percent
A	$	1,094,006	41	%	$	915,632	21	%
B	$	392,321	15	%	$	235,714	5	%
C	$	333,674	12	%	$	198,251	4	%
D	$	200,875	8	%	$	2,379,078	55	%
E	$	—	—	%	$	516,174	12	%

Net sales

Concentration of credit risk and major customers

Schedule of concentration of risk by factors

	September 30, 2013				September 30, 2012
Customer	Dollars		Percent		Dollars		Percent
A	$	2,991,169	24	%	$	1,631,652	11	%
B	$	2,948,045	24	%	$	2,335,696	15	%
C	$	1,300,063	10	%	$	478,360	3	%
D	$	608,328	5	%	$	2,898,858	19	%
E	$	774,184	6	%	$	3,361,526	22	%

XML

CAPITAL STOCK (Details) (USD $)	0 Months Ended	6 Months Ended				1 Months Ended	12 Months Ended
	Feb. 15, 2011	Sep. 30, 2012	Sep. 30, 2013	Mar. 31, 2013	Sep. 30, 2013 Minimum item	Dec. 31, 2009 Series A convertible preferred stock	Mar. 31, 2013 Series A convertible preferred stock	Sep. 30, 2013 Series A convertible preferred stock item
Capital stock
Number of authorized shares			10,000,000	10,000,000
Number of series of preferred stock					1			1
Conversion ratio prior to adjustment						1
Conversion ratio						1.3072
Effective conversion price (in dollars per share)						$ 0.218
Number of shares of common stock issuable upon conversion of convertible preferred stock							7,232,735	7,232,735
Required price per share upon liquidation								$ 0.285
Shares converted into common stock		697,984					1,502,984
Number of shares of common stock issued for converted preferred stock		912,400					1,964,694
Shares outstanding							5,532,998	5,532,998
Term of warrants	2 years
Warrants issued (in shares)	100,000
Shares of common stock that can be purchased through warrants	100,000
Exercise price of warrants (in dollars per share)	$ 1.65
Risk free rate (as a percent)	0.30%
Volatility (as a percent)	79.00%
Expected term	1 year
Value of warrants upon exercise (in dollars per share)	$ 0.51
Fair value of warrants issuable (in dollars)	$ 51,428
Warrants outstanding (in shares)				0
Number of authorized common shares			90,000,000	90,000,000
Number of outstanding common shares			19,956,871	19,956,871

XML

PROPERTY, PLANT AND EQUIPMENT (Tables)

6 Months Ended

Sep. 30, 2013

PROPERTY, PLANT AND EQUIPMENT

Schedule of components of property, plant and equipment, net

	September 30, 2013			March 31, 2013
Land	$	110,113		$	110,113
Building and improvements	3,261,680			3,261,680
Machinery equipment, furniture and fixtures	8,882,938			8,826,050
Equipment under capital leases	65,568			46,378
Total property, plant and equipment	12,320,299			12,244,221
Less: accumulated depreciation	(5,413,017		)	(4,943,973		)
Total property, plant and equipment, net	$	6,907,282		$	7,300,248

XML

DESCRIPTION OF BUSINESS

6 Months Ended

Sep. 30, 2013

DESCRIPTION OF BUSINESS

DESCRIPTION OF BUSINESS

NOTE 1 – DESCRIPTION OF BUSINESS

TechPrecision Corporation offers a full range of services required to transform metallic raw materials into precise finished products We manufacture large scale metal fabricated and machined precision components and equipment. These products are used in a variety of  markets including the alternative energy, medical, nuclear, defense, commercial, and aerospace industries. We sell to customers in three main industry groups: naval/maritime, energy and precision industrial.

We are a Delaware corporation organized in February 2005 under the name Lounsberry Holdings II, Inc. The name was changed to TechPrecision Corporation on March 6, 2006. TechPrecision is the parent company of Ranor, Inc., or Ranor, a Delaware corporation. On November 4, 2010 TechPrecision announced it completed the formation of a wholly foreign owned enterprise (WFOE), under the laws of the People’s Republic of China, Wuxi Critical Mechanical Components Co., Ltd., or WCMC, to meet growing demand for local manufacturing of components in China. TechPrecision, WCMC and Ranor are collectively referred to as the “Company”, “we”, “us” or “our”.

Liquidity and Capital Resources

At September 30, 2013, we were in default and continue to be in default with the Loan and Security Agreement between Ranor and Sovereign Bank, or the Bank, dated February 24, 2006, as amended, or the Loan Agreement. At March 31, 2013, we were not in compliance with the fixed charges and interest coverage financial covenants under the Loan Agreement, and the Bank did not agree to waive our non-compliance with the covenants. As a result, we were in default at March 31, 2013. In addition, the Bank did not renew the revolving credit facility which expired on July 31, 2013. The Bank has the right to accelerate payment of the debt in full upon 60 days written notice. As a consequence, all amounts under the Loan Agreement are classified as a current liability at September 30, 2013 ($5.4 million) and March 31, 2013 ($5.8 million). The Bank continues to evaluate its course of action and has not yet demanded repayment. We continue to make payments pursuant to the terms of the Loan Agreement. If the Bank were to make such a demand for repayment, we would be unable to pay the obligation as we do not have existing facilities or sufficient cash on hand to satisfy these obligations and would need to seek alternative financing. The covenants under the loan agreement are no longer being tested on a monthly, quarterly or annual basis.

We have incurred net losses of $2.2 million for the first six months of the year ending March 31, 2014, or fiscal 2014, and $2.4 million and $2.1 million for the annual periods ended March 31, 2013 and 2012, respectively. At September 30, 2013 we had cash and cash equivalents of $1.5 million of which $0.1 million is located in China and which we may not be able to repatriate for use in the U.S. without undue cost or expense if at all. We borrowed $0.5 million under our revolving line of credit during the quarter ended March 31, 2013, and repaid this borrowing in full in July 2013. In addition, we have $0.9 million of restricted cash with the Bank (included in our other current assets) that could be used toward satisfying our obligation under the Loan Agreement.

These factors raise substantial doubt about our ability to continue as a going concern. In order for us to continue operations beyond the next twelve months and be able to discharge our liabilities and commitments in the normal course of business, we must secure long-term financing on terms consistent with our business plans. In addition, we must increase our backlog and change the composition of our revenues to focus on recurring unit of delivery projects rather than custom first article and prototyping projects which do not efficiently use our manufacturing capacity, and reduce our operating expenses to be in line with current business conditions in order to increase profit margins and decrease the amount of cash used in operations. If we are successful in changing the composition of revenue and reducing costs, we expect that fiscal 2014 operating results will reflect positive operating cash flows. However, we plan to closely monitor our expenses and, if required, will further reduce operating costs and capital spending to enhance liquidity.

The condensed consolidated financial statements for the three and six months ended September 30, 2013 and the year ended March 31, 2013, or fiscal 2013, were prepared on the basis of a going concern which contemplates that we will be able to realize assets and discharge liabilities in the normal course of business. Accordingly, they do not give effect to adjustments that would be necessary should we be required to liquidate assets. Our ability to satisfy our total current liabilities of $10.1 million at September 30, 2013 and to continue as a going concern is dependent upon the availability of and our ability to timely secure long-term financing and the successful execution of our operating plan. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.

XML

RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS

6 Months Ended

Sep. 30, 2013

RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS

RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS

NOTE 3 – RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS

In July 2013, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update (ASU) No. 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (a consensus of the FASB Emerging Issues Task Force), or ASU 2013-11, which provides clarification on the financial statement presentation of unrecognized tax benefits. ASU 2013-11 specifies that an unrecognized tax benefit (or a portion thereof) shall be presented in the financial statements as a reduction to a deferred tax asset when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. If such deferred tax asset is not available at the reporting date to settle additional income taxes resulting from the disallowance of a tax position, or the entity does not plan to use the deferred tax asset for such purpose given the option, the unrecognized tax benefit shall be presented in the financial statements as a liability and shall not be combined with deferred tax assets. The amendments in ASU 2013-11 are effective for fiscal years (and interim periods within those years) beginning after December 15, 2013, with early adoption permitted. We are currently evaluating the impact of adopting ASU 2013-11, but do not believe the new guidance will have a material impact on the balance sheet presentation of its unrecognized tax benefits based on the nature of these items.

In July 2013, the FASB issued No. ASU 2013-10, Derivatives and Hedging — Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purpose, or ASU 2013-10, permitting entities to designate the Fed Funds Effective Swap Rate as a U.S. benchmark interest rate for hedge accounting purposes. Prior to the issuance of this guidance, only interest rates on direct treasury obligations of the U.S. government and the LIBOR swap rate were considered benchmark interest rates in the U.S. This guidance is effective immediately and can be applied prospectively for qualifying new or re-designated hedging relationships entered into on or after July 17, 2013. We do not use the Fed Funds Effective Swap Rate as a benchmark interest rate.

In March 2013, the FASB issued ASU No. 2013-05, Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity, ASU 2013-05, provides guidance for the treatment of the cumulative translation adjustment when an entity ceases to hold a controlling financial interest in a subsidiary or group of assets within a foreign entity. ASU 2013-05 is effective for interim and annual reporting periods beginning after December 15, 2013. We are currently evaluating the impact of adopting ASU 2013-05 on our results of operations, financial position or cash flows.

In February 2013, the FASB issued ASU No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, or ASU 2013-02, requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under U.S. GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under U.S. GAAP that provide additional detail about those amounts. The new guidance is effective prospectively for fiscal years (and interim periods within those years) beginning after December 15, 2013, with early adoption permitted. The Company does not believe that the new guidance will have a material impact on our financial position and results of operations.

XML

OTHER CURRENT ASSETS

6 Months Ended

Sep. 30, 2013

OTHER CURRENT ASSETS

OTHER CURRENT ASSETS

NOTE 6 – OTHER CURRENT ASSETS

	September 30, 2013		March 31, 2013
Payments advanced to suppliers	$	229,449	$	267,513
Prepaid insurance	151,316		187,086
Collateral deposits (see Note 8)	927,462		1,032,348
Deferred loan costs, net of amortization	42,201		57,930
Other	37,965		33,607
Total	$	1,388,393	$	1,578,484

XML

PROPERTY, PLANT AND EQUIPMENT

6 Months Ended

Sep. 30, 2013

PROPERTY, PLANT AND EQUIPMENT

PROPERTY, PLANT AND EQUIPMENT

NOTE 4 – PROPERTY, PLANT AND EQUIPMENT

	September 30, 2013			March 31, 2013
Land	$	110,113		$	110,113
Building and improvements	3,261,680			3,261,680
Machinery equipment, furniture and fixtures	8,882,938			8,826,050
Equipment under capital leases	65,568			46,378
Total property, plant and equipment	12,320,299			12,244,221
Less: accumulated depreciation	(5,413,017		)	(4,943,973		)
Total property, plant and equipment, net	$	6,907,282		$	7,300,248

Depreciation expense for the three and six months ended September 30, 2013 and 2012 was $220,604 and $469,044, and $195,727 and $388,650, respectively.

XML

RELATED PARTY TRANSACTIONS (Details) (USD $)	6 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Related party transactions
Percentage of dilutive equity interest held by the common share holder	36.00%
WCMC | Affiliate of CSI
Related party transactions
Area of office space leased (in square feet)	1,000
Initial lease term	2 years
Annual rent	$ 17,000
CSI
Related party transactions
Percentage of dilutive equity interest held by the common share holder	5.00%
Payments for materials and manufacturing services	$ 0	$ 500,000

XML

ACCRUED EXPENSES (Tables)

6 Months Ended

Sep. 30, 2013

ACCRUED EXPENSES

Schedule of accrued expenses

	September 30, 2013		March 31, 2013
Accrued compensation	$	413,901	$	668,038
Interest rate swaps market value	271,168		388,982
Customer deposits	—		236,000
Other	118,892		311,732
Total	$	803,961	$	1,604,752

XML

SEGMENT INFORMATION (Tables)

6 Months Ended

Sep. 30, 2013

SEGMENT INFORMATION

Schedule of geographic information (net sales and net property, plant and equipment) by the country in which the legal subsidiary is domiciled and assets are located

	Net Sales				Property, Plant and Equipment, Net
	Six months ended September 30, 2013		Six months ended September 30, 2012		September 30, 2013		March 31, 2013
United States	$	12,075,203	$	13,667,736	$	6,895,557	$	7,252,027
China	$	217,284	$	1,556,555	$	11,725	$	19,346

XML

OTHER CURRENT ASSETS (Details) (USD $)	Sep. 30, 2013	Mar. 31, 2013
OTHER CURRENT ASSETS
Payments advanced to suppliers	$ 229,449	$ 267,513
Prepaid insurance	151,316	187,086
Collateral deposits	927,462	1,032,348
Deferred loan costs, net of amortization	42,201	57,930
Other	37,965	33,607
Total	$ 1,388,393	$ 1,578,484

XML

CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS (Details) (USD $)	3 Months Ended		6 Months Ended		12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Mar. 31, 2013
Concentration of credit risk and major customers
Accounts receivable balance	$ 2,690,517		$ 2,690,517		$ 4,330,637
Net sales	5,195,795	8,078,552	12,292,487	15,224,291	32,472,919
Receivable balance | Customer concentration
Concentration of credit risk and major customers
Number of major customers			3
Concentration risk percentage			68.00%
Receivable balance | Customer concentration | Customer A
Concentration of credit risk and major customers
Accounts receivable balance	1,094,006		1,094,006		915,632
Concentration risk percentage			41.00%		21.00%
Receivable balance | Customer concentration | Customer B
Concentration of credit risk and major customers
Accounts receivable balance	392,321		392,321		235,714
Concentration risk percentage			15.00%		5.00%
Receivable balance | Customer concentration | Customer C
Concentration of credit risk and major customers
Accounts receivable balance	333,674		333,674		198,251
Concentration risk percentage			12.00%		4.00%
Receivable balance | Customer concentration | Customer D
Concentration of credit risk and major customers
Accounts receivable balance	200,875		200,875		2,379,078
Concentration risk percentage			8.00%		55.00%
Receivable balance | Customer concentration | Customer E
Concentration of credit risk and major customers
Accounts receivable balance					516,174
Concentration risk percentage					12.00%
Net sales | Customer concentration | Customer A
Concentration of credit risk and major customers
Net sales			2,991,169	1,631,652
Concentration risk percentage			24.00%	11.00%
Net sales | Customer concentration | Customer B
Concentration of credit risk and major customers
Net sales			2,948,045	2,335,696
Concentration risk percentage			24.00%	15.00%
Net sales | Customer concentration | Customer C
Concentration of credit risk and major customers
Net sales			1,300,063	478,360
Concentration risk percentage			10.00%	3.00%
Net sales | Customer concentration | Customer D
Concentration of credit risk and major customers
Net sales			608,328	2,898,858
Concentration risk percentage			5.00%	19.00%
Net sales | Customer concentration | Customer E
Concentration of credit risk and major customers
Net sales			$ 774,184	$ 3,361,526
Concentration risk percentage			6.00%	22.00%

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Sep. 30, 2013	Mar. 31, 2013
Accounts receivable, allowance for doubtful accounts (in dollars)	$ 25,010	$ 25,010
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, liquidation preference (in dollars)	$ 1,576,904	$ 1,576,904
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	90,000,000	90,000,000
Common stock, shares issued	19,956,871	19,956,871
Common stock, shares outstanding	19,956,871	19,956,871
Series A Convertible Preferred Stock
Preferred stock, designated as Series A Convertible Preferred Stock	9,890,980	9,890,980
Preferred stock, shares issued	5,532,998	5,532,998
Preferred stock, shares outstanding	5,532,998	5,532,998

XML

INCOME TAXES

6 Months Ended

Sep. 30, 2013

INCOME TAXES

INCOME TAXES

NOTE 9 – INCOME TAXES

At the end of each interim period, we make an estimate of our annual U.S. and China expected effective tax rates. For the three and six months ended September 30, 2013 we recorded income tax expense of $0 and $0, respectively, and for the three and six months ended September 30, 2012, we recorded an income tax benefit of $11,342 and $278,599, respectively. The lack of a tax benefit for the three and six months ended September 30, 2013 was primarily the result of recording a full valuation allowance on our net deferred tax assets. A valuation allowance must be established for deferred tax assets when it is more likely than not that they will not be realized. The assessment was based on the weight of negative evidence at the balance sheet date, our recent operating losses and unsettled circumstances that, if unfavorably resolved, would adversely affect future operations and profit levels. We have determined that it is more likely than not that certain future tax benefits may not be realized.  A change in the estimates used to make this determination could require an increase in deferred tax assets if they become realizable.

As of September 30, 2013, our federal net operating loss carry-forward was approximately $2.3 million. If not utilized, the federal net operating loss carry-forward will begin to expire in 2025. Section 382 of the Internal Revenue Code provides for a limitation on the annual use of net operating loss carryforwards following certain ownership changes that could limit our ability to utilize these carryforwards on a yearly basis. We experienced an ownership change in connection with the acquisition of Ranor in 2006.

We file income tax returns in the U.S. federal jurisdiction, and various state jurisdictions. Our foreign subsidiary files separate income tax returns in the foreign jurisdiction in which it is located.  Tax years 2010 and forward remain open for examination.  We recognize interest and penalties accrued related to income tax liabilities in selling, general and administrative expense in our Condensed Consolidated Statements of Operations.

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (2,242,575)	$ (751,289)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	478,902	415,429
Stock based compensation expense	214,287	282,719
Deferred income taxes		(282,020)
Provision for contract losses	1,427,803	83,196
Changes in operating assets and liabilities:
Accounts receivable	1,644,073	219,289
Costs incurred on uncompleted contracts, in excess of progress billings	(765,743)	(948,192)
Inventories - raw materials	1,283	(202,361)
Other current assets	180,499	61,199
Taxes receivable		553,070
Other noncurrent assets		88,126
Accounts payable	(1,295,237)	664,632
Accrued expenses	(682,920)	(1,036,974)
Deferred revenues	423,547	931,453
Net cash (used in) provided by operating activities	(616,081)	78,277
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment	(53,941)	(75,109)
Net cash used in investing activities	(53,941)	(75,109)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayment of debt	(875,278)	(683,928)
Net cash used in financing activities	(875,278)	(683,928)
Effect of exchange rate on cash and cash equivalents	1,950	(3,969)
Net decrease in cash and cash equivalents	(1,543,350)	(684,729)
Cash and cash equivalents, beginning of period	3,075,376	2,823,485
Cash and cash equivalents, end of period	1,532,026	2,138,756
Cash paid during the period for:
Interest	127,306	140,138
SUPPLEMENTAL INFORMATION - NONCASH INVESTING AND FINANCING TRANSACTIONS:
Common stock issued in conversion of Series A Convertible Preferred Stock (in shares)		912,400
Series A Convertible Preferred Stock converted (in shares)		697,984
Capital lease arrangement for new office equipment		46,378
Liability recorded for fair value of an interest rate swap contract in connection with a tax exempt bond	271,168	275,315
Tax on liability recorded for fair value of an interest rate swap contract in connection with a tax exempt bond	$ 0	$ 179,339

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2013	Mar. 31, 2013
Current assets:
Cash and cash equivalents	$ 1,532,026	$ 3,075,376
Accounts receivable, less allowance for doubtful accounts of $25,010 in 2013 and 2012	2,690,517	4,330,637
Costs incurred on uncompleted contracts, in excess of progress billings	5,064,036	4,298,293
Inventories- raw materials	355,168	354,516
Income taxes receivable	374,030	374,030
Current deferred taxes	255,765	255,765
Other current assets	1,388,393	1,578,484
Total current assets	11,659,935	14,267,101
Property, plant and equipment, net	6,907,282	7,300,248
Total assets	18,567,217	21,567,349
Current liabilities:
Accounts payable	1,247,729	2,537,060
Contract loss provision	1,697,975	270,172
Accrued expenses	803,961	1,604,752
Accrued taxes payable	232,624	232,624
Deferred revenues	677,907	253,813
Short-term debt		500,000
Current maturity of long-term debt	5,418,227	5,784,479
Total current liabilities	10,078,423	11,182,900
Long-term debt, including capital leases	43,532	31,108
Noncurrent deferred taxes	255,765	255,765
Commitments and contingent liabilities (see Note 16)
Stockholders' Equity:
Preferred stock- par value $.0001 per share, 10,000,000 shares authorized, of which 9,890,980 are designated as Series A Preferred Stock, with 5,532,998 shares issued and outstanding at September 30, 2013 and March 31, 2013, (liquidation preference of $1,576,904 at September 30, 2013 and March 31, 2013)	1,310,206	1,310,206
Common stock -par value $.0001 per share, authorized, 90,000,000 shares issued and outstanding, 19,956,871 shares at September 30, 2013 and March 31, 2013	1,996	1,996
Additional paid in capital	5,290,840	5,076,552
Accumulated other comprehensive loss	(101,210)	(221,418)
Retained earnings	1,687,665	3,930,240
Total stockholders' equity	8,189,497	10,097,576
Total liabilities and stockholders' equity	$ 18,567,217	$ 21,567,349

XML

DEBT (Tables)

6 Months Ended

Sep. 30, 2013

DEBT

Schedule of outstanding debt obligations

Debt obligations outstanding were classified as of:	September 30, 2013		March 31, 2013
Sovereign Bank Capital Expenditure Note due November 2014	$	229,824	$	306,432
Sovereign Bank Staged Advance Note due March 2016	287,482		333,850
MDFA Series A Bonds due January 2021	3,683,333		3,789,583
MDFA Series B Bonds due January 2018	1,207,143		1,346,429
Obligations under capital leases	10,445		8,185
Total short-term debt	$	5,418,227	$	5,784,479
Long-term obligations under capital leases	43,532		31,108
Total debt	$	5,461,759	$	5,815,587

XML

SUBSEQUENT EVENTS

6 Months Ended

Sep. 30, 2013

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS

NOTE 18 – SUBSEQUENT EVENTS

In October 2013 we completed a workforce reduction action that resulted in a 19% reduction in the work force. The cost of this action will result in a charge to operating expenses of approximately $0.1 million which will be paid out before the end of fiscal 2014. This action was prompted by management’s plan to realign our cost structure so we can return to profitability at current revenue levels.

XML

STOCK BASED COMPENSATION (Details) (USD $)	6 Months Ended	12 Months Ended	6 Months Ended		0 Months Ended
	Sep. 30, 2013	Mar. 31, 2013	Sep. 30, 2013 Director	Sep. 30, 2013 Director Minimum item	Jun. 13, 2013 Executive Chairman item	Jun. 13, 2013 Executives item	Jun. 13, 2013 Non-employee directors item
Share based compensation
Number of directors on a committee to administer the plan				2
Maximum number of shares authorized to be issued	3,300,000
Terms of options			5 years
Options granted (in shares)	400,000		50,000		100,000	300,000	200,000
Annual grants (in shares)			10,000
Exercise price of shares granted (in dollars per share)	$ 0.670				$ 0.67	$ 0.67	$ 0.67
Vesting period					10 years	10 years	10 years
Number of equal annual installments in which options will vest					3	3	3
Assumption used in valuation of stock options
Yield term of U.S. Treasury issues on which risk free interest rate is based	5 years
Volatility rate (as a percent)	100.70%
Risk free interest rate (as a percent)	1.10%
Expected term	6 years
Additional general disclosure
Common stock available for grant under plan (in shares)	1,268,506
Number Of Options
Outstanding at the beginning of the period (in shares)	2,484,000
Granted (in shares)	400,000		50,000		100,000	300,000	200,000
Forfeited (in shares)	(1,331,000)
Outstanding at the end of the period (in shares)	1,553,000	2,484,000
Vested or expected to vest at the end of the period (in shares)	1,553,000
Exercisable at the end of the period (in shares)	1,001,667
Weighted Average Exercise Price
Outstanding at the beginning of the period (in dollars per share)	$ 1.027
Granted (in dollars per share)	$ 0.670				$ 0.67	$ 0.67	$ 0.67
Forfeited (in dollars per share)	$ 0.952
Outstanding at the end of the period (in dollars per share)	$ 0.970	$ 1.027
Vested or expected to vest at the end of the period (in dollars per share)	$ 0.970
Exercisable at the end of the period (in dollars per share)	$ 0.986
Aggregate Intrinsic Value
Outstanding at the end of the period	$ 17,750	$ 776,475
Vested or expected to vest at the end of the period	17,750
Exercisable at the end of the period	17,750
Weighted Average Remaining Contractual Life
Outstanding at the end of the period	7 years 2 months 1 day	9 years 25 days
Vested or expected to vest at the end of the period	7 years 2 months 1 day
Exercisable at the end of the period	5 years 2 months 19 days
Additional information on stock options
Unrecognized compensation cost related to stock options	350,652
Period of recognition of unrecognized compensation expense	4 years
Fair value of shares vested	$ 174,905
Stock options outstanding but not vested, Number of Options
Outstanding at the beginning of the period (in shares)	854,334
Granted (in shares)	400,000		50,000		100,000	300,000	200,000
Vested (in shares)	(155,334)
Forfeited (in shares)	(547,667)
Outstanding at the end of the period (in shares)	551,333	854,334
Stock options outstanding but not vested, Weighted Average Exercise Price
Outstanding at the beginning of the period (in dollars per share)	$ 1.249
Granted (in dollars per share)	$ 0.670				$ 0.67	$ 0.67	$ 0.67
Vested (in dollars per share)	$ 1.126
Forfeited (in dollars per share)	$ 1.171
Outstanding at the end of the period (in dollars per share)	$ 0.941	$ 1.249

XML

DEBT (Details) (USD $)	1 Months Ended	6 Months Ended				6 Months Ended		1 Months Ended			3 Months Ended		3 Months Ended	6 Months Ended					1 Months Ended				3 Months Ended	6 Months Ended				6 Months Ended	0 Months Ended				0 Months Ended	6 Months Ended		6 Months Ended			6 Months Ended				6 Months Ended					1 Months Ended	6 Months Ended		6 Months Ended				1 Months Ended	6 Months Ended		1 Months Ended	6 Months Ended
	Aug. 31, 2011	Sep. 30, 2013	Sep. 30, 2012	Mar. 31, 2013	Sep. 30, 2013 Other current assets	Sep. 30, 2013 MLSA and Eighth Amendment Minimum	Sep. 30, 2013 MLSA and Eighth Amendment Maximum	Jun. 30, 2013 Eleventh Amendment	Mar. 31, 2013 Eleventh Amendment	Dec. 31, 2012 Eleventh Amendment	Sep. 30, 2012 Eleventh Amendment	Jul. 06, 2012 Eleventh Amendment	Sep. 30, 2012 Eleventh Amendment Minimum	Sep. 30, 2013 Eleventh Amendment Minimum	Sep. 30, 2013 Eleventh Amendment Maximum	Sep. 30, 2013 ISDA Master Agreement	Mar. 31, 2013 ISDA Master Agreement	Jan. 03, 2011 ISDA Master Agreement item	Dec. 31, 2013 Twelfth Amendment	Sep. 30, 2013 Twelfth Amendment	Jun. 30, 2013 Twelfth Amendment	Mar. 31, 2013 Twelfth Amendment	Mar. 31, 2013 Twelfth Amendment	Sep. 30, 2013 Twelfth Amendment	Dec. 31, 2012 Twelfth Amendment	Feb. 14, 2013 Twelfth Amendment	Sep. 30, 2013 Twelfth Amendment Other current assets	Sep. 30, 2013 Twelfth Amendment Maximum	Mar. 01, 2013 Sovereign Bank Secured Term Note due March, 2013	Feb. 24, 2006 Sovereign Bank Secured Term Note due March, 2013	Sep. 30, 2013 Sovereign Bank Secured Term Note due March, 2013	Mar. 31, 2013 Sovereign Bank Secured Term Note due March, 2013	Jan. 29, 2007 Sovereign Bank Capital Expenditure Note due November 2014	Sep. 30, 2013 Sovereign Bank Capital Expenditure Note due November 2014	Mar. 31, 2013 Sovereign Bank Capital Expenditure Note due November 2014	Sep. 30, 2013 Sovereign Bank Staged Advance Note due March 2016	Mar. 31, 2013 Sovereign Bank Staged Advance Note due March 2016	Mar. 29, 2010 Sovereign Bank Staged Advance Note due March 2016	Sep. 30, 2013 Sovereign Bank Staged Advance Note due March 2016 Maximum	Sep. 30, 2013 Bonds financing	Jan. 31, 2011 Bonds financing	Dec. 30, 2010 Bonds financing	Sep. 30, 2013 MDFA Series A Bonds due January 2021	Mar. 31, 2013 MDFA Series A Bonds due January 2021	Oct. 28, 2011 MDFA Series A Bonds due January 2021	Sep. 30, 2011 MDFA Series A Bonds due January 2021	Dec. 30, 2010 MDFA Series A Bonds due January 2021	Dec. 31, 2010 MDFA Series A Bonds due January 2021 Ranor Inc. sqft	Sep. 30, 2013 MDFA Series A Bonds due January 2021 Maximum	Sep. 30, 2013 MDFA Series A Bonds due January 2021 ISDA Master Agreement	Sep. 30, 2013 MDFA Series B Bonds due January 2018	Mar. 31, 2013 MDFA Series B Bonds due January 2018	Dec. 30, 2010 MDFA Series B Bonds due January 2018	Sep. 30, 2013 MDFA Series B Bonds due January 2018 ISDA Master Agreement	Apr. 30, 2012 Long-term obligations under capital leases	Sep. 30, 2013 Long-term obligations under capital leases	Mar. 31, 2013 Long-term obligations under capital leases	Jul. 31, 2013 Revolving Note	Sep. 30, 2013 Revolving Note	Mar. 31, 2013 Revolving Note	Feb. 24, 2006 Revolving Note
Debt and capital lease obligations
Total short-term debt		$ 5,418,227		$ 5,784,479																														$ 229,824	$ 306,432	$ 287,482	$ 333,850						$ 3,683,333	$ 3,789,583							$ 1,207,143	$ 1,346,429				$ 10,445	$ 8,185
Long-term obligations under capital leases		43,532		31,108
Total debt		5,461,759		5,815,587
Aggregate principal amount																														4,000,000												6,200,000					4,250,000						1,950,000
Maximum borrowings																																	3,000,000	3,000,000		1,900,000		1,900,000																					2,000,000		2,000,000
Ratio of earnings to cover fixed charges (as a percent)						120.00%								125.00%									(81.00%)		(41.00%)
Actual ratio of earnings to cover interest charges (as a percent)																							(351.00%)		(256.00%)
Interest coverage ratio that must be exceeded						2							2	2
Leverage ratio covenant							3								2													2
Actual leverage ratio											1											1	1		1
Term of debt																														7 years
Initial interest rate (as a percent)																														9.00%											1.96%
Variable interest basis																													Prime Rate					LIBOR		LIBOR				one-month LIBOR																			Prime Rate
Interest margin (as a percent)																													1.50%			4.75%		3.00%		4.00%				2.75%																			1.50%
Effective interest rate at end of period (as a percent)																																		3.18%		4.18%				3.725%
Amount of principal payable in quarterly installments																													142,857
Amount borrowed and outstanding under the facility																															0	0																												500,000
Value of property after appraisal	4,800,000
Loan-to-value ratio (as a percent)																																																	75.00%
Maximum loan amount																																											3,600,000
Amount by which bond balance exceeded the maximum loan amount																																														490,000
Current monthly debt principal amount																																											17,708								23,214
Required earnings before interest and taxes													1
EBIT											14,286
Cash collateral deposit					83,219																																								490,000
Additional cash collateral in restricted cash account												840,000														840,000	844,243
Period of written notice to accelerate payment of the debt in full in case of default		60 days																						60 days
Amounts reclassified as a current liability due to default, under the loan and security agreement		5,400,000		5,800,000																5,400,000		5,800,000	5,800,000	5,400,000
Trailing period used for quarterly determination of the ratio of earnings available to cover fixed charges and the interest ratio coverage under the terms of the loan covenants								12 months	9 months	6 months									12 months	9 months	6 months	3 months
Bank fee paid												10,000														7,500
Area of land financed for expansion (in square feet)																																																19,500
Interest rate percentage multiplier																																								65.00%
Fixed interest rate (as a percent)																																																		4.14%				3.63%
Number of interest rate swap transactions																		2
Notional amount of interest rate swap cash flow hedges																4,900,000	5,600,000
Borrowing limit as a percentage of accounts receivable																																																											70.00%
Borrowing limit as a percentage of inventory																																																											40.00%
Funds available for borrowing																																				0																								1,500,000
Amount of Revolving Note repaid																																																										500,000
Initial maximum loan amount																																	500,000
Period of amortization of debt instrument																																		5 years		5 years
Percentage of purchase price of gantry mill machine used for determination of aggregate amount of advances																																							80.00%
Amount of the lease recorded in property, plant and equipment, net																																																								53,977	37,544
Capital lease obligation for new office equipment			46,378																																																				46,378
Capital lease term																																																							63 months
Capital lease term extension																																																								9 months
Capital lease interest rate (as a percent)																																																								6.00%
Capital lease monthly payment																																																								$ 860

XML

PROPERTY, PLANT AND EQUIPMENT (Details) (USD $)	3 Months Ended		6 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Mar. 31, 2013
PROPERTY, PLANT AND EQUIPMENT
Total property, plant and equipment	$ 12,320,299		$ 12,320,299		$ 12,244,221
Less: accumulated depreciation	(5,413,017)		(5,413,017)		(4,943,973)
Total property, plant and equipment, net	6,907,282		6,907,282		7,300,248
Depreciation expense	220,604	195,727	469,044	388,650
Land
PROPERTY, PLANT AND EQUIPMENT
Total property, plant and equipment	110,113		110,113		110,113
Building and improvements
PROPERTY, PLANT AND EQUIPMENT
Total property, plant and equipment	3,261,680		3,261,680		3,261,680
Machinery equipment, furniture and fixtures
PROPERTY, PLANT AND EQUIPMENT
Total property, plant and equipment	8,882,938		8,882,938		8,826,050
Equipment under capital leases
PROPERTY, PLANT AND EQUIPMENT
Total property, plant and equipment	$ 65,568		$ 65,568		$ 46,378

XML

COSTS INCURRED ON UNCOMPLETED CONTRACTS (Details) (USD $)	3 Months Ended		6 Months Ended		12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Mar. 31, 2013
Cost incurred on uncompleted contracts
Cost incurred on uncompleted contracts, beginning balance			$ 6,180,839	$ 10,879,743	$ 10,879,743
Total cost incurred on contracts during the period			11,190,624		21,215,441
Less cost of sales, during the period	(4,468,523)	(6,140,187)	(11,144,972)	(12,180,487)	(25,914,345)
Cost incurred on uncompleted contracts, ending balance	6,226,491		6,226,491		6,180,839
Billings on uncompleted contracts
Billings on uncompleted contracts, beginning balance			1,882,546	6,969,717	6,969,717
Plus: Total billings incurred on contracts, during the period			11,572,396		27,385,748
Less: Contracts recognized as revenue, during the period	(5,195,795)	(8,078,552)	(12,292,487)	(15,224,291)	(32,472,919)
Billings on uncompleted contracts, ending balance	1,162,455		1,162,455		1,882,546
Cost incurred on uncompleted contracts
Cost incurred on uncompleted contracts, ending balance	6,226,491		6,226,491		6,180,839
Billings on uncompleted contracts, ending balance	1,162,455		1,162,455		1,882,546
Costs incurred on uncompleted contracts, in excess of progress billings	5,064,036		5,064,036		4,298,293
Deferred revenues	677,907		677,907		253,813
Contract losses			$ 1,400,000

XML

DEBT

6 Months Ended

Sep. 30, 2013

DEBT

DEBT

NOTE 8 – DEBT

Debt obligations outstanding were classified as of:	September 30, 2013		March 31, 2013
Sovereign Bank Capital Expenditure Note due November 2014	$	229,824	$	306,432
Sovereign Bank Staged Advance Note due March 2016	287,482		333,850
MDFA Series A Bonds due January 2021	3,683,333		3,789,583
MDFA Series B Bonds due January 2018	1,207,143		1,346,429
Obligations under capital leases	10,445		8,185
Total short-term debt	$	5,418,227	$	5,784,479
Long-term obligations under capital leases	43,532		31,108
Total debt	$	5,461,759	$	5,815,587

On February 24, 2006, we entered into the Loan Agreement, with the Bank which has since been amended as further described below. Pursuant to the Loan Agreement, as amended, the Bank provided us with a secured term loan of $4.0 million, or the Term Note, and a revolving line of credit of up to $2.0 million, or Revolving Note. On January 29, 2007, the Loan Agreement was amended, adding a capital expenditure line of credit facility of $3.0 million, or Capital Expenditure Note. On March 29, 2010, the Bank agreed to extend to us a loan facility, or Staged Advance Note, in the amount of up to $1.9 million for the purpose of acquiring a gantry mill machine.

On December 30, 2010, we completed a $6.2 million tax exempt bond financing with the Massachusetts Development Finance Authority, or the MDFA, pursuant to which the MDFA sold to the Bank MDFA Revenue Bonds, Ranor Issue, Series 2010A in the original aggregate principal amount of $4.25 million, or Series A Bonds, and MDFA Revenue Bonds, Ranor Issue, Series 2010B in the original aggregate principal amount of $1.95 million, or Series B Bonds. We refer to Series A Bonds and the Series B Bonds together as the Bonds. The proceeds of such sales were loaned to us under the terms of a Mortgage Loan and Security Agreement, dated as of December 1, 2010, by and among us, MDFA and the Bank (as Bond owner and disbursing Agent), or the MLSA.

In connection with the December 30, 2010 bond financing, we executed an Eighth Amendment to the Loan Agreement, or Eighth Amendment. The Eighth Amendment incorporated borrowing of the Bond proceeds into the borrowings covered by the Loan Agreement. The MLSA provides for customary events of default, including any event of default under the Loan Agreement described above. Subject to lapse of any applicable cure period, a default under the MLSA would cause the acceleration of all of our outstanding obligations under the MLSA. Under the MLSA and the Eighth Amendment, we were required, as of the end of each fiscal quarter, to meet certain financial covenants applicable while the Bonds remain outstanding, including, among other things, that the ratio of earnings available to cover fixed charges will be greater than or equal to 120%; the interest coverage ratio will equal or exceed 2:1; and that our leverage ratio will be less than or equal to 3:1.

On August 8, 2011, an appraisal was completed on our Westminster, Massachusetts property assigning a value of $4.8 million to such property. The Series A Bonds require that the loan-to-value ratio not exceed 75%, indicating a maximum loan amount of $3.6 million. The bond balance exceeded such maximum loan amount at September 30, 2011 by approximately $490,000. On October 28, 2011, we and the Bank agreed to resolve the collateral shortfall by establishing a separate interest bearing restricted cash account in the amount of $490,000 which is pledged as additional collateral to the debt and restricted from use for any other purpose. The required restricted balance is being amortized down at the current monthly debt principal amount of $17,708. At September 30, 2013, the restricted cash is classified as a collateral deposit in other current assets of $83,219.

At December 31, 2011, we were in compliance with our leverage ratio bank covenant. However, we did not meet the ratio of earnings available to cover fixed charges or the interest coverage ratio covenants. In February 2012, we executed a Tenth Amendment and obtained a waiver of the breach of such covenants from the Bank, which waiver covered the breach that otherwise would have occurred in connection with the covenant testing for the third quarter ended December 31, 2011 and waived the ratio of earnings available to cover fixed charges covenant at March 31, 2012. This waiver did not apply to any future covenant testing dates.

On July 6, 2012, we executed an Eleventh Amendment and obtained a waiver for failure to comply with the fixed charge coverage ratio and the interest coverage ratio covenants at March 31, 2012. The Eleventh Amendment also waived the covenant testing requirements related to the ratio of earnings available to cover fixed charges and the interest coverage ratio for the fiscal quarters ended June 30, 2012 and September 30, 2012. The leverage ratio covenant remained in effect, and must not be greater than 2:1. We were in compliance with the leverage ratio covenant at September 30, 2012, as the actual leverage ratio was 1:1. Although there was no testing of the covenant to comply with the ratio of earnings available to cover fixed charges and the interest coverage covenants for the fiscal quarters ended June 30 and September 30, 2012, the Bank required that we have earnings before interest and taxes (EBIT) greater than $1 for the fiscal quarter ended September 30, 2012. We reported EBIT of $14,286 for the fiscal quarter ended September 30, 2012 and, therefore, were in compliance with this covenant. The $1 EBIT covenant at September 30, 2012 is not applicable to any future periods as testing of all covenants resumed on December 31, 2012 according to the terms of the Eleventh Amendment.

Under the Eleventh Amendment the covenants were revised such that we were not to permit earnings available for fixed charges to be less than 125%, the interest coverage ratio to be less than 2:1, and the leverage ratio to be greater than 2:1 at any time, tested quarterly. Also, in connection with the Eleventh Amendment, we paid the Bank a fee of $10,000 and made a collateral deposit of $840,000 to cover estimated principal and interest on our obligation. This collateral was to be released to us upon successful compliance with all debt covenant tests. The Eleventh Amendment also revised covenant testing to provide that the ratio of earnings available to cover fixed charges and the interest coverage ratio covenant testing was to resume at December 31, 2012 on a trailing six month basis, and continue at March 31, 2013 on a trailing nine month basis and quarterly thereafter on a trailing twelve month basis beginning on June 30, 2013.

On February 14, 2013, we executed a Twelfth Amendment and obtained a waiver for failure to comply with the fixed charge coverage ratio and the interest coverage ratio covenants at December 31, 2012. The actual fixed charge ratio at December 31, 2012 was negative 41% and the actual interest coverage ratio was negative 256% as we reported an operating loss for the three months ended December 31, 2012. The leverage ratio covenant remained in effect (and must not be greater than 2:1). We were in compliance with the leverage ratio covenant at December 31, 2012, as the actual leverage ratio was 1:1. The Twelfth Amendment revised the covenant to provide that the ratio of earnings available to cover fixed charges and the interest ratio coverage covenant testing resumed at March 31, 2013 on a trailing three month basis, and continued at June 30, 2013 on a trailing six month basis, at September 30, 2013 on a trailing nine month basis, and quarterly thereafter on a trailing twelve month basis beginning at December 31, 2013. Also, in connection with the Twelfth Amendment, we paid the Bank a fee of $7,500 and were required to continue to maintain a collateral deposit of $840,000 to cover estimated principal and interest on our obligation. A collateral deposit of $844,243 is included in other current assets at September 30, 2013.

At September 30, 2013, we were in default and continue to be in default with the Loan Agreement with the Bank. At March 31, 2013, we were not in compliance with the fixed charges and interest coverage financial covenants under the Loan Agreement, and the Bank did not agree to waive the non-compliance with the covenants. As a result, we were in default at March 31, 2013. In addition, the Bank did not renew the revolving credit facility which expired on July 31, 2013. The Bank has the right to accelerate payment of the debt in full upon 60 days written notice. As a consequence, all amounts under the Loan Agreement are classified as a current liability at September 30, 2013 ($5.4 million) and March 31, 2013 ($5.8 million). The Bank continues to evaluate its course of action and has not yet demanded repayment. We continue to make payments pursuant to the terms of the Loan Agreement. If the Bank were to make such a demand for repayment, we would be unable to pay the obligation as we do not have existing facilities or sufficient cash on hand to satisfy these obligations and would need to seek alternative financing.

At March 31, 2013 the actual fixed charge ratio was negative 81% and the actual interest coverage ratio was negative 351% as we reported an operating loss for the three months ended March 31, 2013. The leverage ratio covenant remained in effect (and must not be greater than 2:1). We were in compliance with the leverage ratio covenant at March 31, 2013, as the actual leverage ratio was 1:1. The covenants under the loan agreement are no longer being tested on a monthly, quarterly or annual basis.

Term Note:

The Term Note issued on February 24, 2006 has a term of 7 years with an initial fixed interest rate of 9%. The interest rate on the Term Note converted from a fixed rate of 9% to a variable rate on February 28, 2011. From February 28, 2011 until maturity the Term Note will bear interest at the Prime Rate plus 1.5% (4.75% at March 31, 2013), payable on a quarterly basis. Principal was paid in quarterly installments of $142,857, plus interest, with a final payment made on March 1, 2013. There was $0 and $0 outstanding under this facility at September 30, 2013 and March 31, 2013, respectively.

MDFA Series A and B Bonds

On December 30, 2010, we and Ranor completed a $6.2 million tax exempt bond financing with the MDFA pursuant to which the MDFA sold the Bonds to the Bank and loaned the proceeds of such sale to Ranor under the terms of the MLSA.

The proceeds from the sale of the Series A Bonds were used to finance the Ranor facility acquisition and 19,500 sq. ft. expansion of Ranor’s manufacturing facility located in Westminster, Massachusetts, and the proceeds from the sale of the Series B Bonds were used to finance acquisitions of qualifying manufacturing equipment installed at the Westminster facility. Under the MLSA and related documents, the Westminster facility secures, and we further guarantee, Ranor’s obligations to the Bank and subsequent holders of the Bonds.

The initial rate of interest on the Bonds was 1.96% for a period from the bond date to and including January 31, 2011, and the interest rate thereafter is 65% times the sum of 275 basis points plus one-month LIBOR. The interest rate at September 30, 2013 was 3.725%. We are required to make monthly payments of $17,708 and $23,214 with respect to the Loans beginning on February 1, 2011 until the maturity date or earlier redemption of each Bond. The Series A Bonds and the Series B Bonds will mature on January 1, 2021 and January 1, 2018, respectively. The Bonds are redeemable pursuant to the MLSA prior to maturity, in whole or in part, on any payment date in accordance with the terms of the MLSA.

In connection with the Bond financing, we and the Bank entered into the International Swap and Derivatives Association, Inc. 2002 Master Agreement, dated December 30, 2010, or ISDA Master Agreement, pursuant to which the variable interest rates applicable to the Bonds were swapped for fixed interest rates of 4.14% on the Series A Bonds and 3.63% on the Series B Bonds. Under the ISDA Master Agreement, we and the Bank entered into two swap transactions, each with an effective date of January 3, 2011. The notional amount of outstanding fair value interest rate swaps totaled $4.9 and $5.6 million at September 30, 2013 and March 31, 2013, respectively. These derivative instruments, which are designated as cash flow hedges, are carried on our consolidated balance sheet at fair value with the effective portion of the gain or loss on the derivative reported in stockholders’ equity as a component of accumulated other comprehensive loss and subsequently reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. The swaps will terminate on January 4, 2021 and January 2, 2018, respectively. The fair value of the interest rate swaps contracts were measured using market based level 2 inputs. The method employed to calculate the values conforms to the industry convention. The swap’s market value can be calculated any time by comparing the fixed rate set at the inception of the transaction and the “swap replacement rate,” which represents the market rate for an offsetting interest rate swap with the same Notional Amounts and final maturity date. The market value is then determined by calculating the present value interest differential between the contractual swap and the replacement swap. The termination value is the sum of the present value interest differential as described above plus the accrued interest due at termination.

Revolving Note:

We and the Bank agreed to extend the maturity date of the revolving credit facility to July 29, 2012 under the Ninth Amendment to the Loan Agreement. The maturity date of the revolving credit facility was extended to January 31, 2013 under the Eleventh Amendment, and was extended further to July 31, 2013 under the Twelfth Amendment. The Revolving Note bears interest at a variable rate determined as the Prime Rate, plus 1.5% annually on any outstanding balance. The borrowing limit on the Revolving Note is limited to the sum of 70% of our eligible accounts receivable plus 40% of eligible inventory up to a maximum borrowing limit of $2.0 million. In July 2013, we repaid the $500,000 borrowed under the Revolving Note. This facility expired by its terms on July 31, 2013 and was not renewed by the Bank. As of March 31, 2013 there was $500,000 borrowed and outstanding under this facility and $1.5 million was available under this facility.

Capital Expenditure Note:

The initial borrowing limit under the Capital Expenditure Note was $0.5 million and has been amended several times resulting in a borrowing limit of $3.0 million. On November 30, 2009, we elected not to renew this facility when it terminated. Borrowings outstanding under this facility were converted to a note when the facility terminated. The current rate of interest is LIBOR plus 3% or 3.18% at September 30, 2013. Principal and interest payments are due monthly based on a five year amortization schedule. The Capital Expenditure Note matures on November 30, 2014.

Staged Advance Note:

The Bank made certain loans to us limited to a cap of $1.9 million for the purpose of acquiring a gantry mill machine. The machine serves as collateral for the loan. The total aggregate amount of advances under this agreement could not exceed 80% of the actual purchase price of the gantry mill machine. All advances provided for a payment of interest only monthly through February 28, 2011, and thereafter, no further borrowings were permitted under this facility. The current interest rate is LIBOR plus 4% or 4.18% at September 30, 2013. Beginning on April 1, 2011, we were obligated to pay principal and interest sufficient to amortize the outstanding balance on a five year schedule. The Staged Advance Note matures on March 1, 2016.

Capital Lease:

We entered into a new capital lease in April 2012 in the amount of $46,378 for certain office equipment. The original lease term is for 63 months, bears interest at 6.0% and requires monthly payments of principal and interest of $860. This lease was amended in fiscal 2014 when we purchased another replacement copier at Ranor. The revised lease term was extended by nine months and will expire in March 2018. The amount of the lease recorded in property, plant and equipment, net was $53,977 and $37,544 as of September 30, 2013 and March 31, 2013, respectively.

XML

STOCK BASED COMPENSATION (Tables)

6 Months Ended

Sep. 30, 2013

STOCK BASED COMPENSATION

Summary of information about options for the most recent annual income statements presented

	Number Of		Weighted Average		Aggregate Intrinsic		Weighted Average Remaining Contractual Life
	Options		Exercise Price		Value		(in years)
Outstanding at 3/31/2013	2,484,000		$	1.027	$	776,475	9.07
Granted	400,000		$	0.670	—		—
Forfeited	(1,331,000	)	$	0.952	—		—
Outstanding at 9/30/2013	1,553,000		$	0.970	$	17,750	7.17
Vested or expected to vest 9/30/2013	1,553,000		$	0.970	$	17,750	7.17
Exercisable at 9/30/2013	1,001,667		$	0.986	$	17,750	5.22

Summary of activity of stock options outstanding but not vested

	Number of Options		Weighted Average
Outstanding at 3/31/2013	854,334		$	1.249
Granted	400,000		$	0.670
Vested	(155,334	)	$	1.126
Forfeited	(547,667	)	$	1.171
Outstanding at 9/30/2013	551,333		$	0.941

XML

PROFIT SHARING PLAN (Details) (Ranor, Inc., USD $)	3 Months Ended		6 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Ranor, Inc.
PROFIT SHARING PLAN
Eligibility for employer matching contributions, period of service			90 days
Matching contributions made by the company	$ 3,093	$ 5,543	$ 6,725	$ 10,703

XML

PROFIT SHARING PLAN

6 Months Ended

Sep. 30, 2013

PROFIT SHARING PLAN

PROFIT SHARING PLAN

NOTE 11 – PROFIT SHARING PLAN

Ranor has a 401(k) profit sharing plan that covers substantially all Ranor employees who have completed 90 days of service. Ranor retains the option to match employee contributions. Our contributions were $3,093 and $6,725, for the three and six months ended September 30, 2013, respectively, and $5,543 and $10,703, for the three and six months ended September 30, 2012.

XML

ACCRUED EXPENSES

6 Months Ended

Sep. 30, 2013

ACCRUED EXPENSES

ACCRUED EXPENSES

NOTE 7 - ACCRUED EXPENSES

	September 30, 2013		March 31, 2013
Accrued compensation	$	413,901	$	668,038
Interest rate swaps market value	271,168		388,982
Customer deposits	—		236,000
Other	118,892		311,732
Total	$	803,961	$	1,604,752

XML

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

6 Months Ended

Sep. 30, 2013

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying condensed consolidated financial statements include the accounts of TechPrecision, WCMC and Ranor. Intercompany transactions and balances have been eliminated in consolidation. The accompanying condensed consolidated balance sheet as of September 30, 2013, the condensed consolidated statements of operations and comprehensive loss for the three and six months periods ended September 30, 2013 and 2012, and the condensed consolidated statements of cash flows for the six months ended September 30, 2013 and 2012 are unaudited, but in the opinion of management, include all adjustments that are necessary for a fair presentation of our financial statements for interim periods in accordance with U.S. Generally Accepted Accounting Principles, or U.S. GAAP. All adjustments are of a normal, recurring nature, except as otherwise disclosed. The results of operations for an interim period are not necessarily indicative of the results of operations to be expected for the fiscal year.

The Notes to Condensed Consolidated Financial Statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission, or SEC, for Quarterly Reports on Form 10-Q. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. These unaudited financial statements and related notes should be read in conjunction with our consolidated financial statements included with our Annual Report on Form 10-K, or 2013 Form 10-K, filed with the SEC for the year ended March 31, 2013.

Significant Accounting Policies

Our significant accounting policies are set forth in detail in Note 2 to the 2013 Form 10-K.

XML

COMMITMENTS (Details) (USD $)	Sep. 30, 2013
COMMITMENTS
Aggregate annual commitment for future salaries during the next twelve months, excluding bonuses	$ 1,000,000

XML

EARNINGS PER SHARE (EPS) (Tables)

6 Months Ended

Sep. 30, 2013

EARNINGS PER SHARE (EPS)

Schedule of reconciliation of the numerators and denominators reflected in the basic and diluted loss per share computations

	Three Months ended September 30,			Three Months ended September 30,			Six Months ended September 30,			Six Months ended September 30,
	2013			2012			2013			2012
Basic EPS
Net Loss	$	(818,670	)	$	(45,020	)	$	(2,242,575	)	$	(751,289	)
Weighted average number of shares outstanding	19,956,871			18,696,846			19,956,871			18,614,112
Basic income (loss) per share	$	(0.04	)	$	(0.00	)	$	(0.11	)	$	(0.04	)
Diluted EPS
Net Loss	$	(818,670	)	$	(45,020	)	$	(2,242,575	)	$	(751,289	)
Dilutive effect of stock options, warrants and preferred stock	—			—			—			—
Diluted weighted average shares	19,956,871			18,696,846			19,956,871			18,614,112
Diluted loss per share	$	(0.04	)	$	(0.00	)	$	(0.11	)	$	(0.04	)

XML

CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS

6 Months Ended

Sep. 30, 2013

CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS

CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS

NOTE 14 – CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS

We maintain bank account balances, which, at times, may exceed insured limits. We have not experienced any losses with these accounts and believe that we are not exposed to any significant credit risk on cash. At September 30, 2013, there were accounts receivable balances outstanding from three customers comprising 68% of the total receivables balance.

The following table sets forth information as to accounts receivable from customers who accounted for more than 10% of our accounts receivable balance as of:

	September 30, 2013				March 31, 2013
Customer	Dollars		Percent		Dollars		Percent
A	$	1,094,006	41	%	$	915,632	21	%
B	$	392,321	15	%	$	235,714	5	%
C	$	333,674	12	%	$	198,251	4	%
D	$	200,875	8	%	$	2,379,078	55	%
E	$	—	—	%	$	516,174	12	%

We have been dependent in each year on a small number of customers who generate a significant portion of our business, and these customers change from year to year. The following table sets forth information as to net sales from customers who accounted for more than 10% of our revenue for the six months ended:

	September 30, 2013				September 30, 2012
Customer	Dollars		Percent		Dollars		Percent
A	$	2,991,169	24	%	$	1,631,652	11	%
B	$	2,948,045	24	%	$	2,335,696	15	%
C	$	1,300,063	10	%	$	478,360	3	%
D	$	608,328	5	%	$	2,898,858	19	%
E	$	774,184	6	%	$	3,361,526	22	%

XML

RELATED PARTY TRANSACTIONS

6 Months Ended

Sep. 30, 2013

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS

NOTE 10 – RELATED PARTY TRANSACTIONS

WCMC leased approximately 1,000 sq. ft. of office space from an affiliate of Cleantech Solutions International, or CSI, to serve as its primary office location in Wuxi, China. This lease expired on August 31, 2013. We are currently leasing the same space on a month to month basis. The original lease had an initial two-year term and rent under the lease with the CSI affiliate was approximately $17,000 on an annual basis. In addition to leasing property from an affiliate of CSI, we subcontract fabrication and machining services from CSI through their manufacturing facility in Wuxi, China and such subcontracted services are overseen by our personnel co-located at CSI in Wuxi, China. During the lease period, we viewed CSI as a related party because a holder of an approximate 5% fully diluted equity interest in CSI also held an approximate 36% fully diluted equity interest in TechPrecision. We paid $0 and $0.5 million to CSI for materials and manufacturing services for the six months ended September 30, 2013 and 2012, respectively. WCMC is also subcontracting manufacturing services from other non-related party Chinese manufacturing companies on comparable terms as those it had with CSI.

XML

EARNINGS PER SHARE (EPS)

6 Months Ended

Sep. 30, 2013

EARNINGS PER SHARE (EPS)

EARNINGS PER SHARE (EPS)

NOTE 17 – EARNINGS PER SHARE (EPS)

Basic EPS is computed by dividing reported earnings available to stockholders by the weighted average shares outstanding. Diluted EPS also includes the effect of dilutive potential common shares. The following table provides a reconciliation of the numerators and denominators reflected in the basic and diluted loss per share computations, as required under FASB ASC 260.

	Three Months ended September 30,			Three Months ended September 30,			Six Months ended September 30,			Six Months ended September 30,
	2013			2012			2013			2012
Basic EPS
Net Loss	$	(818,670	)	$	(45,020	)	$	(2,242,575	)	$	(751,289	)
Weighted average number of shares outstanding	19,956,871			18,696,846			19,956,871			18,614,112
Basic income (loss) per share	$	(0.04	)	$	(0.00	)	$	(0.11	)	$	(0.04	)
Diluted EPS
Net Loss	$	(818,670	)	$	(45,020	)	$	(2,242,575	)	$	(751,289	)
Dilutive effect of stock options, warrants and preferred stock	—			—			—			—
Diluted weighted average shares	19,956,871			18,696,846			19,956,871			18,614,112
Diluted loss per share	$	(0.04	)	$	(0.00	)	$	(0.11	)	$	(0.04	)

All potential common share equivalents that have an anti-dilutive effect (i.e. those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS. For the three and six month periods ended September 30, 2013, there were 5,011,341 and 5,359,626 shares, respectively, and for the three and six months ended September 30, 2012 there were 5,808,674 and 6,907,806 shares, respectively, of potentially anti-dilutive stock options, warrants and convertible preferred stock, none of which were included in the EPS calculations above.

XML

SEGMENT INFORMATION

6 Months Ended

Sep. 30, 2013

SEGMENT INFORMATION

SEGMENT INFORMATION

NOTE 15 – SEGMENT INFORMATION

We consider our business to consist of one segment - metal fabrication and precision machining. A significant amount of our operations, assets and customers are located in the United States. The following table presents our geographic information (net sales and net property, plant and equipment) by the country in which the legal subsidiary is domiciled and assets are located:

	Net Sales				Property, Plant and Equipment, Net
	Six months ended September 30, 2013		Six months ended September 30, 2012		September 30, 2013		March 31, 2013
United States	$	12,075,203	$	13,667,736	$	6,895,557	$	7,252,027
China	$	217,284	$	1,556,555	$	11,725	$	19,346

XML

Document and Entity Information	6 Months Ended
	Sep. 30, 2013	Nov. 08, 2013
Document and Entity Information
Entity Registrant Name	TECHPRECISION CORP
Entity Central Index Key	0001328792
Document Type	10-Q
Document Period End Date	Sep. 30, 2013
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		19,956,871
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q2

XML

COMMITMENTS

6 Months Ended

Sep. 30, 2013

COMMITMENTS

COMMITMENTS

NOTE 16 – COMMITMENTS

We have employment agreements with our executive officers. Such agreements provide for minimum salary levels, adjusted annually, as well as for incentive bonuses that are payable if specified company goals are attained. The aggregate annual commitment at September 30, 2013 for future salaries during the next twelve months, excluding bonuses, was approximately $1,000,000.